This is a Validated Antibody Database (VAD) review about human CD25, based on 292 published articles (read how Labome selects the articles), using CD25 antibody in all methods. It is aimed to help Labome visitors find the most suited CD25 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD25 synonym: CD25; IDDM10; IL2R; IMD41; TCGFR; p55

BioLegend
mouse monoclonal (BC96)
  • flow cytometry; mouse
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on mouse samples . Mol Ther Oncolytics (2022) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 7a
BioLegend CD25 antibody (BioLegend, 302631) was used in flow cytometry on human samples (fig 7a). Cell Rep (2022) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 2e
BioLegend CD25 antibody (Biolegend, 302606) was used in flow cytometry on human samples (fig 2e). Biomark Res (2022) ncbi
mouse monoclonal (BC96)
  • flow cytometry; mouse; loading ...; fig s4e
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on mouse samples (fig s4e). J Immunother Cancer (2021) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 4c
BioLegend CD25 antibody (Biolegend, 302606) was used in flow cytometry on human samples (fig 4c). Cell Rep Med (2021) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 6b
BioLegend CD25 antibody (BioLegend, 302 614) was used in flow cytometry on human samples (fig 6b). Adv Sci (Weinh) (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD25 antibody (Biolegend, 356107) was used in flow cytometry on human samples (fig 1a). Cell Host Microbe (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
BioLegend CD25 antibody (Biolegend, 356115) was used in flow cytometry on human samples . Aging (Albany NY) (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s2d
BioLegend CD25 antibody (Biolegend, 356104) was used in flow cytometry on human samples (fig s2d). Cell Death Dis (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3b
BioLegend CD25 antibody (Biolegend, M-A251) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s3a
BioLegend CD25 antibody (BioLegend, 302632) was used in flow cytometry on human samples (fig s3a). Immunity (2021) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples . Immunity (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
BioLegend CD25 antibody (Biolegend, M-A251) was used in flow cytometry on human samples . EMBO Mol Med (2021) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...
BioLegend CD25 antibody (BioLegend, 302608) was used in flow cytometry on human samples . Cell (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s6-2
BioLegend CD25 antibody (BioLegend, MA251) was used in flow cytometry on human samples (fig s6-2). elife (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 6c
BioLegend CD25 antibody (Biolegend, M-A251) was used in flow cytometry on human samples (fig 6c). Cell Death Dis (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 3b
BioLegend CD25 antibody (Biolegend, 356102) was used in flow cytometry on human samples (fig 3b). elife (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; mouse; 1:100; loading ...
BioLegend CD25 antibody (Biolegend, M-A25) was used in flow cytometry on mouse samples at 1:100. elife (2020) ncbi
mouse monoclonal (BC96)
  • flow cytometry; mouse; loading ...; fig 2a
BioLegend CD25 antibody (BioLegend, 302636) was used in flow cytometry on mouse samples (fig 2a). Cell (2020) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s1d
BioLegend CD25 antibody (Biolegend, 302632) was used in flow cytometry on human samples (fig s1d). Cell (2020) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s6a
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig s6a). J Clin Invest (2020) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1c
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1c). JCI Insight (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s20
BioLegend CD25 antibody (Biolegend, 356113) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; 1:200; loading ...; fig 7c
BioLegend CD25 antibody (BioLegend, 302613) was used in flow cytometry on human samples at 1:200 (fig 7c). elife (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; 1:100; loading ...; fig 7a
BioLegend CD25 antibody (Biolegend, 302610) was used in flow cytometry on human samples at 1:100 (fig 7a). elife (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 7a, 7b, 7c
BioLegend CD25 antibody (Biolegend, clone BC96) was used in flow cytometry on human samples (fig 7a, 7b, 7c). Sci Rep (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s3d
BioLegend CD25 antibody (Biolegend, 356102) was used in flow cytometry on human samples (fig s3d). Cell (2019) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s3d
BioLegend CD25 antibody (Biolegend, 356102) was used in flow cytometry on human samples (fig s3d). Cell (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3s2b
BioLegend CD25 antibody (Biolegend, 302609) was used in flow cytometry on human samples (fig 3s2b). elife (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; mouse; loading ...; fig 6d
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on mouse samples (fig 6d). J Clin Invest (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s1
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig s1). J Exp Med (2019) ncbi
mouse monoclonal (BC96)
  • other; human; loading ...; fig 4b
BioLegend CD25 antibody (BioLegend, 302643) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD25 antibody (BioLegend, 302610) was used in flow cytometry on human samples (fig 4a). Diagn Pathol (2019) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD25 antibody (Biolegend, M-A251) was used in flow cytometry on human samples (fig 3a). Front Immunol (2019) ncbi
mouse monoclonal (M-A251)
  • mass cytometry; human; loading ...; fig 2b
BioLegend CD25 antibody (Biolegend, 356102) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s2c
BioLegend CD25 antibody (Biolegend, M-A251) was used in flow cytometry on human samples (fig s2c). Arthritis Res Ther (2019) ncbi
mouse monoclonal (BC96)
  • immunocytochemistry; human; loading ...; fig 6c
BioLegend CD25 antibody (Biolegend, 302615) was used in immunocytochemistry on human samples (fig 6c). Sci Rep (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s10d
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig s10d). Nature (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 7a
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 7a). Front Pharmacol (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 3g
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 3g). Cell Stem Cell (2019) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD25 antibody (Biolegend, M-A251) was used in flow cytometry on human samples (fig 3a). Arthritis Res Ther (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; rhesus macaque; loading ...; fig 7a
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; rhesus macaque; loading ...; fig 2f
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on rhesus macaque samples (fig 2f). J Virol (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1e
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1e). PLoS Pathog (2018) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD25 antibody (BioLegend, M-A251) was used in flow cytometry on human samples (fig 1a). Leukemia (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1a
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1a). Bone Marrow Transplant (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1b
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1b). J Exp Med (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1
BioLegend CD25 antibody (BioLegend, M-A251) was used in flow cytometry on human samples (fig 1). Am J Trop Med Hyg (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 4a). Int J Infect Dis (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 7a
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 7a). Nat Immunol (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3d
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 3d). Antimicrob Agents Chemother (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3g
In order to study the involvement of interleukin-8 on T lymphocytes growth and function, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 3g). Int Immunopharmacol (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD25 antibody (BioLegend, 302610) was used in flow cytometry on human samples (fig 2a). J Clin Invest (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 3c). Oncotarget (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD25 antibody (BioLegend, 356130) was used in flow cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
rat monoclonal (7D4/CD25)
  • flow cytometry; mouse; loading ...; fig 7e
In order to examine skin dendritic cells from mice exposed to two different Th2 stimuli, BioLegend CD25 antibody (BioLegend, 7D4) was used in flow cytometry on mouse samples (fig 7e). J Exp Med (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1
In order to study the role of PD-1 and Tim-3 crosstalk in the regulation of antitumor T cell responses, BioLegend CD25 antibody (Biolegend, 302612) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 6f
In order to characterize CD8 positive alpha beta gamma delta T cells, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 6f). J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 7a
In order to determine which cells express CD83, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 7a). J Immunol (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend CD25 antibody (Biolegend, M-A251) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; rhesus macaque; loading ...; fig 2
In order to assess the efficacy of targeting alpha4 beta7 integrin to treat SIV, BioLegend CD25 antibody (BioLegend, 302630) was used in flow cytometry on rhesus macaque samples (fig 2). Science (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s7
In order to investigate how organ-specific Btnl genes shape local T cell compartments, BioLegend CD25 antibody (Biolegend, 302630) was used in flow cytometry on human samples (fig s7). Cell (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s2
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig s2). PLoS Pathog (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; 1:100; fig 3f
In order to investigate the impact of a cancer-specific MUC1 glycoform, BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples at 1:100 (fig 3f). Nat Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 4a). J Exp Med (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; mouse; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on mouse samples . Science (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; African green monkey; loading ...; fig s2
In order to discuss the use of flow cytometry to examine common marmosets, BioLegend CD25 antibody (BioLegend, M-A251) was used in flow cytometry on African green monkey samples (fig s2). J Med Primatol (2016) ncbi
rat monoclonal (7D4/CD25)
  • flow cytometry; mouse; loading ...; fig 2a
In order to investigate the mechanism for adoptively transferred effector T-cell survival and memory formation, BioLegend CD25 antibody (BioLegend, 7D4) was used in flow cytometry on mouse samples (fig 2a). Cell Biosci (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1b). Nat Immunol (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 5b
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend CD25 antibody (BioLegend, M-A251) was used in flow cytometry on human samples (fig 5b). Am J Transplant (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 6b
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 6b). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 8a
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 8a). PLoS Pathog (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s1
BioLegend CD25 antibody (BioLegend, 302609) was used in flow cytometry on human samples (fig s1). Sci Rep (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3b
In order to demonstrate that TGF-beta induces the differentiation of human CXCL13-producing CD4 positive T cells from naive CD4 positive T cells, BioLegend CD25 antibody (BioLegend, M-A251) was used in flow cytometry on human samples (fig 3b). Eur J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
In order to study factors that specify the Treg lineage, BioLegend CD25 antibody (BioLegend, 302606) was used in flow cytometry on human samples (fig 1). elife (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 5a
In order to discuss the importance of IL-5 positive Th2 cells to allergies, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 5a). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; tbl s1
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s1
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig s1). PLoS ONE (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 3a
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 3a). J Immunol Res (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on human samples (fig 1). J Autoimmun (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 4
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples (fig 4). Nat Immunol (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend CD25 antibody (BioLegend, clone BC96) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (BC96)
BioLegend CD25 antibody (Biolegend, 302606) was used . PLoS ONE (2014) ncbi
mouse monoclonal (M-A251)
BioLegend CD25 antibody (Biolegend, M-A251) was used . PLoS ONE (2014) ncbi
mouse monoclonal (BC96)
BioLegend CD25 antibody (Biolegend, 302606) was used . J Biol Chem (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
BioLegend CD25 antibody (Biolegend, BC96) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; chimpanzee
In order to study the in vitro response of gammadelta T-cell subsets from HIV1-infected and control chimpanzees to T-cell activators, BioLegend CD25 antibody (BioLegend, BC96) was used in flow cytometry on chimpanzee samples . J Med Primatol (2014) ncbi
Invitrogen
mouse monoclonal (BC96)
  • flow cytometry; human; 1:50; loading ...
Invitrogen CD25 antibody (Invitrogen, 25-0259-42) was used in flow cytometry on human samples at 1:50. Life Sci Alliance (2022) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...
Invitrogen CD25 antibody (eBioscience, 12-0259-42) was used in flow cytometry on human samples . J Immunother Cancer (2022) ncbi
mouse monoclonal (BC96)
  • flow cytometry; mouse; 1:1000; loading ...
Invitrogen CD25 antibody (Thermo Fisher Scientific, 12-0259-42) was used in flow cytometry on mouse samples at 1:1000. Cell Rep Med (2021) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . Aging Cell (2021) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s1c
Invitrogen CD25 antibody (eBioscience, 12-0259-42) was used in flow cytometry on human samples (fig s1c). Cell (2019) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; 1:100; fig 1b
Invitrogen CD25 antibody (Invitrogen, MHCD2501) was used in flow cytometry on human samples at 1:100 (fig 1b). Nat Commun (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples (fig 1a). Front Immunol (2019) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 5a
Invitrogen CD25 antibody (eBiosciences, BC96) was used in flow cytometry on human samples (fig 5a). Front Immunol (2018) ncbi
mouse monoclonal (CD25-4E3)
  • immunohistochemistry - frozen section; human; fig 1a
Invitrogen CD25 antibody (eBioscience, CD25-4E3) was used in immunohistochemistry - frozen section on human samples (fig 1a). J Exp Med (2018) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1a
In order to study the involvement of Notch signaling in NK cell lineage determination, Invitrogen CD25 antibody (ebioscience, BC96) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig s2k
In order to investigate the role of dopamine in B cell maturation in germinal centres, Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples (fig s2k). Nature (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; tbl 1
In order to investigate infiltrating T cells in liver cancer through single-cell sequencing, Invitrogen CD25 antibody (eBioscience, 12-0259-42) was used in flow cytometry on human samples (tbl 1). Cell (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1f
In order to study the oncogenic role of ERK1 in glioma, Invitrogen CD25 antibody (ebioscience, 17-0259) was used in flow cytometry on human samples (fig 1f). J Immunol (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig s1b
In order to study the differentiation of innate lymphoid cells, Invitrogen CD25 antibody (eBioscience, 48-0259) was used in flow cytometry on human samples (fig s1b). Cell (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...
In order to assess the effects of targeting the chimeric antigen receptors to the TRAC locus, Invitrogen CD25 antibody (eBiosciences, 17-0259-42) was used in flow cytometry on human samples . Nature (2017) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 1a
Invitrogen CD25 antibody (eBiosciences, BC96) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; mouse; fig 1
In order to analyze the induction of immune-mediated survival advantage in murine intracranial glioma by agonist anti-GITR monoclonal antibody and stereotactic radation, Invitrogen CD25 antibody (eBioscience, 25025942) was used in flow cytometry on mouse samples (fig 1). J Immunother Cancer (2016) ncbi
mouse monoclonal (RPA-T4, BC96)
  • flow cytometry; human; fig s1
Invitrogen CD25 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples (fig s1). Cell Rep (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 4
In order to develop an HLA-A2-specific chimeric antigen receptor and use it to generate alloantigen-specific human T regulatory cells, Invitrogen CD25 antibody (eBioscience, 25-0259-42) was used in flow cytometry on human samples (fig 4). J Clin Invest (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 5
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...; fig 4d
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, Invitrogen CD25 antibody (eBioscience, 17-0259-42) was used in flow cytometry on human samples (fig 4d). J Immunol (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (CD25-4E3)
  • flow cytometry; human; fig 4
Invitrogen CD25 antibody (eBioscience, 4E3) was used in flow cytometry on human samples (fig 4). Haematologica (2016) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
Invitrogen CD25 antibody (ebioscience, 17-0259-42) was used in flow cytometry on human samples . Am J Reprod Immunol (2015) ncbi
mouse monoclonal (CD25-4E3)
  • flow cytometry; crab eating macaque; fig s2
Invitrogen CD25 antibody (eBioscience, 4E3) was used in flow cytometry on crab eating macaque samples (fig s2). J Autoimmun (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . Hum Immunol (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig 1
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples (fig 1). Eur J Immunol (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . Cytotherapy (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
In order to developed a strategy to expand umbilical cord blood T cells and test their effects after transplantation, Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . Leukemia (2015) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
  • immunocytochemistry; human
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples and in immunocytochemistry on human samples . Mol Oncol (2014) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . J Immunol (2013) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 1
In order to elucidate the influence of H. pylori on T(reg) function and proliferation, Invitrogen CD25 antibody (Caltag, clone 3G10) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2012) ncbi
mouse monoclonal (RPA-T4, BC96)
  • flow cytometry; human
Invitrogen CD25 antibody (eBioscience, RPA-T4) was used in flow cytometry on human samples . Nat Immunol (2011) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 1
In order to study changes in T cell subsets during HBV infection, Invitrogen CD25 antibody (Invitrogen, MHCD2504) was used in flow cytometry on human samples (fig 1). Immunol Invest (2012) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human; fig S5
In order to examine tumor and nonadjacent normal breast tissue from women with breast cancer, who either had or had not received neoadjuvant chemotherapy before surgery, Invitrogen CD25 antibody (eBioscience, 25-0259-42) was used in flow cytometry on human samples (fig S5). Proc Natl Acad Sci U S A (2012) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 1, 2
In order to examine the impact of Tregs on CAR-modified T cells in the SCID-Beige xenotransplant model, Invitrogen CD25 antibody (Caltag, CD25.3G10) was used in flow cytometry on human samples (fig 1, 2). Cancer Res (2011) ncbi
mouse monoclonal (BC96)
  • flow cytometry; rat; 25 ug/ml; tbl 2
In order to characterize bone marrow-derived mesenchymal stem cells from patients with ankylosing spondylitis, Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on rat samples at 25 ug/ml (tbl 2). Arthritis Res Ther (2011) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 4
In order to discuss the role of T regulatory cells in systemic sclerosis and morphoea, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 4). Br J Dermatol (2010) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
In order to elucidate the role of interleukin-15 in human natural killer cell development, Invitrogen CD25 antibody (eBioscience, BC96) was used in flow cytometry on human samples . J Exp Med (2009) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; rhesus macaque; fig 3
In order to describe how to purify naturally occurring regulatory T cells from rhesus macaques, Invitrogen CD25 antibody (Caltag, 3G10) was used in flow cytometry on rhesus macaque samples (fig 3). Am J Transplant (2008) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 3b
In order to correlate Notch receptor expression and the severity of systemic lupus erythematosus disease, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 3b). Lupus (2008) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 5
In order to determine the safety of microS110 administration, Invitrogen CD25 antibody (Invitrogen, CD25-3G10) was used in flow cytometry on human samples (fig 5). Cancer Immunol Immunother (2009) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 1
In order to examine the frequency, phenotype, and function of T regulatory cells in patients with systemic lupus erythematosus and inactive disease, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 1). Clin Exp Immunol (2008) ncbi
mouse monoclonal (BC96)
  • flow cytometry; human
In order to characterize cellular immunity in patients co-infected with HIV-1 and Mycobacterium leprae, Invitrogen CD25 antibody (e-Bioscience, BC96) was used in flow cytometry on human samples . Immunology (2008) ncbi
mouse monoclonal (B-B10)
  • western blot; hamsters; fig 7
In order to examine if Xenopus paraxial protocahedrin protein oligomerization and/or protein interactions are required for its cell sorting function, Invitrogen CD25 antibody (BioSource/Invitrogen Corp, B-B10) was used in western blot on hamsters samples (fig 7). J Biol Chem (2007) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 6A
In order to propose a model in which the gamma chain cytokines IL-2, IL-4, IL-7, and IL-15 maintain the optimal regulatory function of human CD4+ CD25+ T cells in a PI3K-dependent manner, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 6A). Int Immunol (2007) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 2A
In order to characterize filoviral glycoproteins and study their contribution to infection, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 2A). FASEB J (2006) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 3
In order to discuss methods to purify human CD4+ CD25+ regulatory T cells, Invitrogen CD25 antibody (Caltag, 3G10) was used in flow cytometry on human samples (fig 3). J Immunol Methods (2006) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 1B
In order to assess if there is a CD4+CD25high regulatory T-cell deficit in early rheumatoid arthritis, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 1B). Rheumatology (Oxford) (2006) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 5
In order to test if impaired neonatal CD4 T-cell immunity contributes to the low incidence of acute graft-versus-host disease after allogeneic transplantation of hematopoietic stem cells using cord blood, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 5). Biol Blood Marrow Transplant (2006) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 5
In order to study expression of N-methyl-D-aspartate receptors functionally active in controlling T cell activation by human T lymphocytes, Invitrogen CD25 antibody (Caltag, 3G10) was used in flow cytometry on human samples (fig 5). Biochem Biophys Res Commun (2005) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human
In order to characterize gastric adenocarcinoma with and without residual neoplasic disease, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples . Cancer Immunol Immunother (2006) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human
In order to develop an assay to quantitate the number of latently infected cells carrying replication competent HIV-1, Invitrogen CD25 antibody (Caltag, 3G10) was used in flow cytometry on human samples . Methods Mol Biol (2005) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human
In order to characterize the infiltrating cells in synovial fluid of inflamed joints of patients with rheumatoid arthritis, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples . Ann Rheum Dis (2005) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human
In order to discuss the creation of stable T-cell lines to study their impact in inflammatory bowel disease, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples . Scand J Gastroenterol (2004) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human
In order to test if human fetal liver cells expressing CD34 and CK7/8 represent a common stem cell for both the hematopoietic and hepatic systems, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples . J Hepatol (2004) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 4
In order to study the interactions between CD4(+)CD25(+) T cells and human CD8(+) T cells, Invitrogen CD25 antibody (Caltag, 3G10) was used in flow cytometry on human samples (fig 4). Eur J Immunol (2003) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 4
In order to investigate the involvement of the PD-1 system in rheumatoid arthritis, Invitrogen CD25 antibody (Caltag, 3G10) was used in flow cytometry on human samples (fig 4). J Rheumatol (2003) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human
In order to study T-cell lines from gastric cancer patients and healthy volunteers, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples . Cancer Immunol Immunother (2003) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 1a
In order to characterize CD4(+)CD25(+) human T cells, Invitrogen CD25 antibody (Caltag, 3G10) was used in flow cytometry on human samples (fig 1a). Blood (2001) ncbi
mouse monoclonal (B-B10)
  • flow cytometry; human; fig 1
In order to study the regulatory role of IL-12 in ICAM-1-mediated costimulation, Invitrogen CD25 antibody (BioSource International, B-B10) was used in flow cytometry on human samples (fig 1). J Immunol (2001) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human; fig 4
In order to compare the immune responses of T cells isolated from human secondary lymphoid organs and peripheral blood, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples (fig 4). Int Immunol (2001) ncbi
mouse monoclonal (CD25-3G10)
  • flow cytometry; human
In order to study perturbations in eosinophil homeostasis following treatment of lymphatic filariasis, Invitrogen CD25 antibody (Caltag, CD25-3G10) was used in flow cytometry on human samples . Infect Immun (2000) ncbi
mouse monoclonal (B-B10)
  • flow cytometry; human; fig 2
In order to examine the role of role of neutrophil-derived serine proteases in traumatic brain injuries, Invitrogen CD25 antibody (Biosource, B-B10) was used in flow cytometry on human samples (fig 2). J Interferon Cytokine Res (1999) ncbi
mouse monoclonal (CD25-3G10)
  • blocking or activating experiments; human; 1:256
In order to investigate Tac antigen expression on activated cytotoxic killer T cells, suppressor cells, and helper T cells, Invitrogen CD25 antibody (noco, noca) was used in blocking or activating experiments on human samples at 1:256. J Immunol (1981) ncbi
Abcam
rat monoclonal
  • flow cytometry; mouse; fig 3a
Abcam CD25 antibody (Abcam, ab210332) was used in flow cytometry on mouse samples (fig 3a). Cancer Cell Int (2021) ncbi
mouse monoclonal (MEM-181)
  • immunocytochemistry; mouse; 1:1000
Abcam CD25 antibody (Abcam, ab8235) was used in immunocytochemistry on mouse samples at 1:1000. J Comp Neurol (2014) ncbi
Bio-Rad
mouse monoclonal (AV142)
  • flow cytometry; chicken; fig 1
Bio-Rad CD25 antibody (BIO-RAD AbD Serotec, AV142) was used in flow cytometry on chicken samples (fig 1). Parasite Immunol (2016) ncbi
mouse monoclonal (AV142)
  • flow cytometry; chicken; fig 3
Bio-Rad CD25 antibody (AbD Serotec, AV142) was used in flow cytometry on chicken samples (fig 3). Dev Comp Immunol (2015) ncbi
R&D Systems
domestic goat polyclonal
  • mass cytometry; human; loading ...; fig 2d
R&D Systems CD25 antibody (R&D, AF-223-NA) was used in mass cytometry on human samples (fig 2d). Biomark Res (2022) ncbi
Beckman Coulter
mouse monoclonal (B1.49.9)
  • flow cytometry; human; loading ...; fig s1
Beckman Coulter CD25 antibody (Beckman Coulter, B1.49.9) was used in flow cytometry on human samples (fig s1). EBioMedicine (2020) ncbi
mouse monoclonal (B1.49.9)
  • flow cytometry; human; loading ...; fig s8a
Beckman Coulter CD25 antibody (Beckman Coulter, B1.49.9) was used in flow cytometry on human samples (fig s8a). Nat Commun (2020) ncbi
mouse monoclonal (B1.49.9)
  • flow cytometry; human; loading ...; fig 1
Beckman Coulter CD25 antibody (Beckman Coulter, IM2646U) was used in flow cytometry on human samples (fig 1). Exp Ther Med (2017) ncbi
mouse monoclonal (B1.49.9)
  • flow cytometry; human; loading ...; fig 1a
In order to evaluate the predictive values of the protective T-cell response for human cytomegalovirus disease, Beckman Coulter CD25 antibody (Beckman Coulter-Immunotech, B1.49.9) was used in flow cytometry on human samples (fig 1a). New Microbiol (2016) ncbi
mouse monoclonal (B1.49.9)
  • immunocytochemistry; human
In order to analyze HIV-specific naive and memory CD4(+) T cells through two methods, Beckman Coulter CD25 antibody (Beckman Coulter, B1.49.9) was used in immunocytochemistry on human samples . J Exp Med (2014) ncbi
mouse monoclonal (B1.49.9)
  • flow cytometry; human
Beckman Coulter CD25 antibody (Beckman Coulter, A52882) was used in flow cytometry on human samples . Ann Neurol (2014) ncbi
mouse monoclonal (B1.49.9)
  • flow cytometry; human
Beckman Coulter CD25 antibody (Beckman Coulter, B1.49.9) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
mouse monoclonal (B1.49.9)
  • flow cytometry; human
In order to examine human differentiated effector CD4(+) T cells that are defined by low levels of IL-2 and IL-7 receptors, Beckman Coulter CD25 antibody (Beckman, cB1.49.9) was used in flow cytometry on human samples . Cancer Res (2014) ncbi
mouse monoclonal (B1.49.9)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, Beckman Coulter CD25 antibody (Beckman, B1.49.9) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
Tonbo Biosciences
mouse monoclonal (BC96)
  • flow cytometry; human; loading ...
In order to assess how ABCG1 loss in T cells affects atherosclerosis, Tonbo Biosciences CD25 antibody (Tonbo Biosciences, BC96) was used in flow cytometry on human samples . J Clin Invest (2016) ncbi
BD Biosciences
mouse monoclonal (2A3)
  • flow cytometry; human; 1:50; loading ...; fig 2g
BD Biosciences CD25 antibody (BD, 562661) was used in flow cytometry on human samples at 1:50 (fig 2g). Nat Commun (2022) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; fig s2
BD Biosciences CD25 antibody (BD Bioscience, 2A3) was used in flow cytometry on human samples (fig s2). J Immunother Cancer (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD25 antibody (BD Bioscience, M-A251) was used in flow cytometry on human samples (fig 3a). J Immunother Cancer (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s4d
BD Biosciences CD25 antibody (BD, 555430) was used in flow cytometry on human samples (fig s4d). Science (2021) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 3b
BD Biosciences CD25 antibody (BD, 2A3) was used in flow cytometry on human samples (fig 3b). Acta Neuropathol (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences CD25 antibody (BD, 555431) was used in flow cytometry on human samples (fig 3a). Signal Transduct Target Ther (2021) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD25 antibody (BD, 2A3) was used in flow cytometry on human samples (fig 1). Arthritis Res Ther (2021) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 2i
BD Biosciences CD25 antibody (BD Biosciences, 564033) was used in flow cytometry on human samples (fig 2i). Am J Respir Crit Care Med (2021) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3c
BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples (fig 3c). BMC Cancer (2020) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig s3d
BD Biosciences CD25 antibody (Becton Dickinson, 2A3) was used in flow cytometry on human samples (fig s3d). EBioMedicine (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s3d
BD Biosciences CD25 antibody (Becton Dickinson, M-A251) was used in flow cytometry on human samples (fig s3d). EBioMedicine (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s3b
BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples (fig s3b). Aging (Albany NY) (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1d
BD Biosciences CD25 antibody (BD Biosciences, M-251) was used in flow cytometry on human samples (fig 1d). Arch Immunol Ther Exp (Warsz) (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 7k
BD Biosciences CD25 antibody (BD, MA-251) was used in flow cytometry on human samples (fig 7k). J Exp Med (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 1c
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 1c). J Immunother Cancer (2020) ncbi
mouse monoclonal (2A3)
  • mass cytometry; human; 500 ug/ml; loading ...; fig s11a
BD Biosciences CD25 antibody (BD, 2A3) was used in mass cytometry on human samples at 500 ug/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 14a
BD Biosciences CD25 antibody (BD Biosciences, 560987) was used in flow cytometry on human samples (fig 14a). Hum Vaccin Immunother (2020) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples . PLoS Pathog (2019) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 3f, 3g
BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (fig 3f, 3g). Brain Pathol (2020) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig s7a
BD Biosciences CD25 antibody (BD Biosciences, 340939) was used in flow cytometry on human samples (fig s7a). Cell (2019) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 7a
BD Biosciences CD25 antibody (BD Biosciences, 341009) was used in flow cytometry on human samples (fig 7a). elife (2019) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (fig s3). Eur J Immunol (2019) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 1
BD Biosciences CD25 antibody (BD Pharmingen, 2A3) was used in flow cytometry on human samples (fig 1). Am J Transplant (2019) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s5a
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig s5a). Proc Natl Acad Sci U S A (2018) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; 1:20; loading ...; fig 2a
BD Biosciences CD25 antibody (BD Bioscience, 340907) was used in flow cytometry on human samples at 1:20 (fig 2a). Nat Med (2019) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 5b
BD Biosciences CD25 antibody (BD Biosciences, 564033) was used in flow cytometry on human samples (fig 5b). Nat Immunol (2018) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; tbl 1
BD Biosciences CD25 antibody (BD Biosciences, 560503) was used in flow cytometry on human samples (tbl 1). J Clin Invest (2018) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s2l
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig s2l). JCI Insight (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 4a
BD Biosciences CD25 antibody (BD Biosciences, MA-251) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; tbl s1
In order to investigate the effect of Shigella infection on human lymphocytes, BD Biosciences CD25 antibody (BD Pharmingen, 555432) was used in flow cytometry on human samples (tbl s1). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (fig 5a). Sci Rep (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s1b
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig s1b). PLoS ONE (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1c
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 1c). Sci Rep (2017) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig s3c
In order to report that autosomal recessive, partial Go-Ichi-Ni-San 1 deficiency impairs DNA replication and underlies intra-uterine and postnatal growth retardation, chronic neutropenia, and natural killer cell deficiency, BD Biosciences CD25 antibody (BD, 2A3) was used in flow cytometry on human samples (fig s3c). J Clin Invest (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s1d
In order to examine the effect of glucose-6-phosphate transporter mutation on immune cell homeostasis and CD4+ T cell functions, BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples (fig s1d). J Immunol (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate origin of tumor-infiltrating T regulatory cells in breast cancer samples, BD Biosciences CD25 antibody (BD Pharmingen, 560225) was used in flow cytometry on human samples (fig 3a). Cell Res (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 4d
BD Biosciences CD25 antibody (BD Biosciences, 555432) was used in flow cytometry on human samples (fig 4d). Oncoimmunology (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 5a). Blood (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s3a
BD Biosciences CD25 antibody (BD Bioscience, M-A251) was used in flow cytometry on human samples (fig s3a). Sci Rep (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples (fig 1a). JCI Insight (2017) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 2e
In order to observe that the use of chimeric antigen receptor technology is a clinically applicable refinement of regulatory T cell therapy for organ transplantation, BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (fig 2e). Am J Transplant (2017) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s1c
In order to describe complete autosomal recessive IL-17RA deficiency in patients with chronic mucocutaneous candidiasis, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig s1c). Proc Natl Acad Sci U S A (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 1a
In order to establish the T Cell receptor-inducible costimulator as a promising target for direct T regulatory cell-targeting therapeutic agents for gastric cancer, BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (fig 1a). Int J Cancer (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BD Biosciences CD25 antibody (BD, MA- 251) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3a
In order to investigate the basis for T regulatory cell accumulation in melanoma, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 3a). Cancer Res (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig 4a
In order to report that patients with PTEN mutations experience autoimmunity and lymphoid hyperplasia, BD Biosciences CD25 antibody (BD, 2A3) was used in flow cytometry on human samples (fig 4a). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
In order to utilize humanized major histocompatibility class I- and class II-deficient NOG mice to assess the antitumor effect of an anti-programmed death-1 antibody, BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples . Clin Cancer Res (2017) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 8
In order to study the promotion of the development of self-reactive T cells by hydrophobic CDR3 residues, BD Biosciences CD25 antibody (BD Biosciences, 555432) was used in flow cytometry on human samples (fig 8). Nat Immunol (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...
In order to investigate the contribution of NLRP3 inflammasome activity to the T helper cell 1 response, BD Biosciences CD25 antibody (BD Bioscience, 2A3) was used in flow cytometry on human samples . Science (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig s2f
BD Biosciences CD25 antibody (BD, 2A3) was used in flow cytometry on human samples (fig s2f). J Clin Invest (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples . Sci Rep (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
In order to study the role of T regulatory cells in patients with immune thrombocytopenic purpura, BD Biosciences CD25 antibody (BD Pharmingen, 555433) was used in flow cytometry on human samples . Turk J Haematol (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; fig s1
In order to find predictive markers for patients that will develop gastrointestinal graft-versus-host-disease, BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (fig s1). JCI Insight (2016) ncbi
mouse monoclonal (M-A251)
  • western blot; mouse; 1:1000; loading ...; fig s10a
In order to use naked mole-rat-induced pluripotent stem cells to study mechanisms of cancer resistance, BD Biosciences CD25 antibody (BD Biosciences, 555430) was used in western blot on mouse samples at 1:1000 (fig s10a). Nat Commun (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
In order to test if the two hematopoietic systems in patients with mixed chimerism remain functional and study immunological differences, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . PLoS ONE (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; 1:5; tbl 2
BD Biosciences CD25 antibody (BD PharMingen, 555434) was used in flow cytometry on human samples at 1:5 (tbl 2). Oncoimmunology (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1d
In order to explore the role of the JAK/STAT pathway in controlling Foxp3 in regulatory T cells, BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples (fig 1d). PLoS ONE (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...; fig s2
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BD Biosciences CD25 antibody (BD, 2A3) was used in flow cytometry on human samples (fig s2). Am J Transplant (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD25 antibody (BD, 557138) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
In order to characterize B and T cells from patients with thrombocytopenia, BD Biosciences CD25 antibody (BD Biosciences, 557741) was used in flow cytometry on human samples . Haematologica (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 1
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 2
BD Biosciences CD25 antibody (BD, 555434) was used in flow cytometry on human samples (fig 2). Nat Biotechnol (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 7
BD Biosciences CD25 antibody (BD Biosciences, 555434) was used in flow cytometry on human samples (fig 7). Immunity (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig st1
BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples (fig st1). J Autoimmun (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 2a
In order to examine the contribution of T cells to myasthenia gravis, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 2a). J Immunol (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 5a
BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples (fig 5a). PLoS ONE (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; fig 7.45.3
In order to validate a single-cell measurement, simultaneously, for cell surface proteins, messenger RNA, and intracellular proteins, BD Biosciences CD25 antibody (BD Biosciences, 341010) was used in flow cytometry on human samples (fig 7.45.3). Curr Protoc Cytom (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 5a
In order to study the role of polo-like kinase 1 in essential functions of alloreactive T cells, BD Biosciences CD25 antibody (BD biosciences, M-A251) was used in flow cytometry on human samples (fig 5a). Immunol Res (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 8c
In order to perform an antigenic analysis of Bla g 2 using antibodies, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 8c). J Biol Chem (2016) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; loading ...
In order to study mitochondria of effector memory CD4+ T cells in normoxic and hypoxic conditions, BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples . J Immunol (2016) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig s6
In order to study the use of bispecific T cell engager, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig s6). PLoS ONE (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; 1:25; tbl 1
BD Biosciences CD25 antibody (BD Pharmingen, 555434) was used in flow cytometry on human samples at 1:25 (tbl 1). PLoS ONE (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig s3
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig s3). Sci Transl Med (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 1
BD Biosciences CD25 antibody (BD Biosciences, 560355) was used in flow cytometry on human samples (fig 1). Retrovirology (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 2
BD Biosciences CD25 antibody (BD Biosciences, MA251) was used in flow cytometry on human samples (fig 2). J Clin Invest (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
In order to determine the proportions, phenotype, survival, and apoptotic susceptibility of Tregs in sarcoidosis, BD Biosciences CD25 antibody (BD biosciences, M-A251) was used in flow cytometry on human samples . Respir Res (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 2b
BD Biosciences CD25 antibody (BD PharMingen, 557753) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; 1:100; fig 6
BD Biosciences CD25 antibody (BD Bioscience, 555431) was used in flow cytometry on human samples at 1:100 (fig 6). Stem Cells Int (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
In order to study T cell subtypes in breast cancer patients with and without high levels of autoimmune thyroid antibodies, BD Biosciences CD25 antibody (BD Pharmingen, 555433) was used in flow cytometry on human samples . Cent Eur J Immunol (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1c,1f,5b,5d
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BD Biosciences CD25 antibody (BD, 561405) was used in flow cytometry on human samples (fig 1c,1f,5b,5d). PLoS Pathog (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
In order to investigate the primary inflammatory and regulatory T cell responses induced by BCG vaccination in adults, BD Biosciences CD25 antibody (BD Biosciences, clone M-A251) was used in flow cytometry on human samples . Clin Vaccine Immunol (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 5
BD Biosciences CD25 antibody (BD Bioscience, M-A251) was used in flow cytometry on human samples (fig 5). Nat Immunol (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . Clin Immunol (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...
In order to develop feasible methods to generate cytomegalovirus-specific T cells from naive cells for T cell therapy, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . Sci Transl Med (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 2
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples (fig 2). Retrovirology (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig s3
BD Biosciences CD25 antibody (BD Biosciences, MA-251) was used in flow cytometry on human samples (fig s3). J Infect Dis (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; mouse; fig 3
BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on mouse samples (fig 3). Stem Cell Res (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; 1 ul/test
In order to analyze mucosal pinch biopsies collected predominantly during colonoscopies, BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples at 1 ul/test. J Immunol Methods (2015) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human; fig 1
BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples (fig 1). J Autoimmun (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Bioscience, M-A251) was used in flow cytometry on human samples . Clin Transplant (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Bioscience, M-A251) was used in flow cytometry on human samples . Cell Res (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig s3
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig s3). Diabetes (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Pharmingen, 555431) was used in flow cytometry on human samples . Alcohol (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 6
BD Biosciences CD25 antibody (BD Pharmingen, M-A251) was used in flow cytometry on human samples (fig 6). Stem Cell Res Ther (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; 1:20
BD Biosciences CD25 antibody (BD Biosciences, MA-251) was used in flow cytometry on human samples at 1:20. Autoimmun Rev (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; rhesus macaque
In order to examine the mechanism of anti-alpha4 antibody treatment in monkeys, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on rhesus macaque samples . PLoS Pathog (2014) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human
BD Biosciences CD25 antibody (Becton Dickinson Biosciences, 2A3) was used in flow cytometry on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (Becton Dickinson Biosciences, M-A251) was used in flow cytometry on human samples . J Autoimmun (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples . J Immunol (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples . Nat Commun (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
In order to examine the role of TLR7 in HIV-infected CD4 positive T cells, BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples . Nat Immunol (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 2
BD Biosciences CD25 antibody (BD Biosciences, MA-251) was used in flow cytometry on human samples (fig 2). Cancer Immunol Immunother (2015) ncbi
mouse monoclonal (M-A251)
  • immunocytochemistry; mouse
BD Biosciences CD25 antibody (PharMingen, M-A251) was used in immunocytochemistry on mouse samples . Hum Pathol (2014) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human
In order to examine the effect of lytic EBV antigen-specific CD8+ T cells on EBV infection in humanized mice, BD Biosciences CD25 antibody (BD Pharmigen, 2A3) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
In order to examine the effect of lytic EBV antigen-specific CD8+ T cells on EBV infection in humanized mice, BD Biosciences CD25 antibody (BD Pharmigen, M-A251) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
In order to study the role of CD93 molecule in mature dendritic cells and T cells, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . Immunobiology (2015) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human
In order to study the role of CD93 molecule in mature dendritic cells and T cells, BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples . Immunobiology (2015) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig s1
In order to investigate the impact of CCR6(+)CXCR3(+)CCR4(-) cells in latent tuberculosis infection, BD Biosciences CD25 antibody (BD Bioscience, M-A251) was used in flow cytometry on human samples (fig s1). J Immunol (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 4b
In order to test if proteasome-inhibition complements the effects of corticosteroids to improve outcomes in chronic graft-versus-host disease, BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples (fig 4b). Biol Blood Marrow Transplant (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 3b
In order to show that latency-associated peptide and glycoprotein A repetitions predominant identify human antigen-specific T regulatory cells, BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples (fig 3b). Eur J Immunol (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; fig 2
BD Biosciences CD25 antibody (Pharmingen, M-A251) was used in flow cytometry on human samples (fig 2). Immunology (2015) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human
In order to investigate the effects of Nucleofection on freshly isolated primary CD4 T cell morphology, intracellular calcium levels, cell surface activation markers, and transcriptional activity, BD Biosciences CD25 antibody (Becton Dickinson Pharmingen, 341009) was used in flow cytometry on human samples . J Immunol Methods (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BD Biosciences CD25 antibody (BD Bioscience, M-A251) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (M-A251)
  • immunocytochemistry; human
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in immunocytochemistry on human samples . Eur J Immunol (2014) ncbi
mouse monoclonal (2A3)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on human samples . PLoS Pathog (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human; loading ...; fig 1
In order to discuss the importance of assessing immune competence in cancer patients, BD Biosciences CD25 antibody (BD, M-A251) was used in flow cytometry on human samples (fig 1). Cancer Immunol Immunother (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD/Pharmingen, M-A251) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
mouse monoclonal (M-A251)
  • flow cytometry; human
BD Biosciences CD25 antibody (BD Biosciences, M-A251) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (2A3)
  • flow cytometry; mouse; fig 1
In order to determine the expression of CD39 in mouse and human T cells, BD Biosciences CD25 antibody (BD Biosciences, 2A3) was used in flow cytometry on mouse samples (fig 1). Blood (2007) ncbi
mouse monoclonal (2A3)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, BD Biosciences CD25 antibody (BDIS, 2A3) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
Leica Biosystems
monoclonal (4C9)
  • immunohistochemistry; human; loading ...; fig s2z
Leica Biosystems CD25 antibody (Leica Biosystems, 4C9) was used in immunohistochemistry on human samples (fig s2z). Neuropathol Appl Neurobiol (2021) ncbi
monoclonal (4C9)
  • immunohistochemistry; human; fig 1e
Leica Biosystems CD25 antibody (Novocastra (Leica), 4C9) was used in immunohistochemistry on human samples (fig 1e). BMC Cancer (2021) ncbi
monoclonal (4C9)
  • immunohistochemistry - paraffin section; human; 1:100; tbl 1
Leica Biosystems CD25 antibody (Novocastra, 4C9) was used in immunohistochemistry - paraffin section on human samples at 1:100 (tbl 1). Rom J Morphol Embryol (2016) ncbi
monoclonal (4C9)
  • immunohistochemistry - paraffin section; human; 1:100; fig 6
Leica Biosystems CD25 antibody (Leica Microsystems, PA0306) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 6). Am J Surg Pathol (2015) ncbi
monoclonal (4C9)
  • immunohistochemistry - paraffin section; human; 1:50
Leica Biosystems CD25 antibody (Leica, 4C9) was used in immunohistochemistry - paraffin section on human samples at 1:50. Int J Lab Hematol (2015) ncbi
monoclonal (4C9)
  • immunohistochemistry - paraffin section; human; 1:50
Leica Biosystems CD25 antibody (Novocastra, 4C9) was used in immunohistochemistry - paraffin section on human samples at 1:50. Br J Dermatol (2015) ncbi
monoclonal (4C9)
  • immunohistochemistry - paraffin section; human
In order to characterize stroma cells and ductal epithelium comparing chronic pancreatitis and pancreatic ductal adenocarcinoma, Leica Biosystems CD25 antibody (Leica Novocastra, 4C9) was used in immunohistochemistry - paraffin section on human samples . PLoS ONE (2014) ncbi
Articles Reviewed
  1. Ravindranathan S, Passang T, Li J, Wang S, Dhamsania R, Ware M, et al. Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma. Nat Commun. 2022;13:6418 pubmed publisher
  2. Kemper K, Gielen E, Boross P, Houtkamp M, Plantinga T, de Poot S, et al. Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models. Life Sci Alliance. 2022;5: pubmed publisher
  3. Ni H, Zhang H, Li L, Huang H, Guo H, Zhang L, et al. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer. J Immunother Cancer. 2022;10: pubmed publisher
  4. Jin Y, Lorvik K, Jin Y, Beck C, Sike A, Persiconi I, et al. Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer. Mol Ther Oncolytics. 2022;26:189-206 pubmed publisher
  5. Saxena V, Piao W, Li L, Paluskievicz C, Xiong Y, Simon T, et al. Treg tissue stability depends on lymphotoxin beta-receptor- and adenosine-receptor-driven lymphatic endothelial cell responses. Cell Rep. 2022;39:110727 pubmed publisher
  6. Jiang Z, Qin L, Tang Y, Liao R, Shi J, He B, et al. Human induced-T-to-natural killer cells have potent anti-tumour activities. Biomark Res. 2022;10:13 pubmed publisher
  7. Wang Z, He L, Li W, Xu C, Zhang J, Wang D, et al. GDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma. J Immunother Cancer. 2021;9: pubmed publisher
  8. Fierle J, Brioschi M, de Tiani M, Wetterwald L, Atsaves V, Abram Saliba J, et al. Soluble trivalent engagers redirect cytolytic T cell activity toward tumor endothelial marker 1. Cell Rep Med. 2021;2:100362 pubmed publisher
  9. Kim G, Kim W, Lim S, Lee H, Koo J, Nam K, et al. In Vivo Induction of Regulatory T Cells Via CTLA-4 Signaling Peptide to Control Autoimmune Encephalomyelitis and Prevent Disease Relapse. Adv Sci (Weinh). 2021;8:2004973 pubmed publisher
  10. Dalla Pietà A, Cappuzzello E, Palmerini P, Ventura A, Visentin A, Astori G, et al. Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. J Immunother Cancer. 2021;9: pubmed publisher
  11. Li N, Torres M, Spetz M, Wang R, Peng L, Tian M, et al. CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice. Cell Rep Med. 2021;2:100297 pubmed publisher
  12. Motozono C, Toyoda M, Zahradník J, Saito A, Nasser H, Tan T, et al. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity. Cell Host Microbe. 2021;29:1124-1136.e11 pubmed publisher
  13. Wu K, Zheng X, Yao Z, Zheng Z, Huang W, Mu X, et al. Accumulation of CD45RO+CD8+ T cells is a diagnostic and prognostic biomarker for clear cell renal cell carcinoma. Aging (Albany NY). 2021;13:14304-14321 pubmed publisher
  14. Zimmer T, Broekaart D, Luinenburg M, Mijnsbergen C, Anink J, Sim N, et al. Balloon cells promote immune system activation in focal cortical dysplasia type 2b. Neuropathol Appl Neurobiol. 2021;47:826-839 pubmed publisher
  15. Zhou S, Meng F, Du S, Qian H, Ding N, Sha H, et al. Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation. J Immunother Cancer. 2021;9: pubmed publisher
  16. Lake C, Voss K, Bauman B, Pohida K, Jiang T, Dveksler G, et al. TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1. Cell Death Dis. 2021;12:400 pubmed publisher
  17. Weber E, Parker K, Sotillo E, Lynn R, Anbunathan H, Lattin J, et al. Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling. Science. 2021;372: pubmed publisher
  18. Ingelfinger F, Krishnarajah S, Kramer M, Utz S, Galli E, Lutz M, et al. Single-cell profiling of myasthenia gravis identifies a pathogenic T cell signature. Acta Neuropathol. 2021;141:901-915 pubmed publisher
  19. Szabo P, Dogra P, Gray J, Wells S, Connors T, Weisberg S, et al. Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. 2021;54:797-814.e6 pubmed publisher
  20. Kuroda H, Jamiyan T, Yamaguchi R, Kakumoto A, Abe A, Harada O, et al. Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast. BMC Cancer. 2021;21:286 pubmed publisher
  21. Chiou S, Tseng D, Reuben A, Mallajosyula V, Molina I, Conley S, et al. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery. Immunity. 2021;54:586-602.e8 pubmed publisher
  22. Mo F, Duan S, Jiang X, Yang X, Hou X, Shi W, et al. Nanobody-based chimeric antigen receptor T cells designed by CRISPR/Cas9 technology for solid tumor immunotherapy. Signal Transduct Target Ther. 2021;6:80 pubmed publisher
  23. Rosshirt N, Trauth R, Platzer H, Tripel E, Nees T, Lorenz H, et al. Proinflammatory T cell polarization is already present in patients with early knee osteoarthritis. Arthritis Res Ther. 2021;23:37 pubmed publisher
  24. Vavassori V, Mercuri E, Marcovecchio G, Castiello M, Schiroli G, Albano L, et al. Modeling, optimization, and comparable efficacy of T cell and hematopoietic stem cell gene editing for treating hyper-IgM syndrome. EMBO Mol Med. 2021;13:e13545 pubmed publisher
  25. Wang J, Li S, Li H, Zhou X, Wen H, Lai B. IRF4 overexpression promotes the transdifferentiation of tregs into macrophage-like cells to inhibit the development of colon cancer. Cancer Cell Int. 2021;21:58 pubmed publisher
  26. Webb L, Fra Bido S, Innocentin S, Matheson L, Attaf N, Bignon A, et al. Ageing promotes early T follicular helper cell differentiation by modulating expression of RBPJ. Aging Cell. 2021;20:e13295 pubmed publisher
  27. Snyder M, Sembrat J, Noda K, MYERBURG M, Craig A, Mitash N, et al. Human Lung-Resident Macrophages Colocalize with and Provide Costimulation to PD1hi Tissue-Resident Memory T Cells. Am J Respir Crit Care Med. 2021;203:1230-1244 pubmed publisher
  28. Lund M, Howard C, Thurecht K, Campbell D, Mahler S, Walsh B. A bispecific T cell engager targeting Glypican-1 redirects T cell cytolytic activity to kill prostate cancer cells. BMC Cancer. 2020;20:1214 pubmed publisher
  29. Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C, et al. Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2021;184:169-183.e17 pubmed publisher
  30. Kasatskaya S, Ladell K, Egorov E, Miners K, Davydov A, Metsger M, et al. Functionally specialized human CD4+ T-cell subsets express physicochemically distinct TCRs. elife. 2020;9: pubmed publisher
  31. Luo B, Zhan Y, Luo M, Dong H, Liu J, Lin Y, et al. Engineering of α-PD-1 antibody-expressing long-lived plasma cells by CRISPR/Cas9-mediated targeted gene integration. Cell Death Dis. 2020;11:973 pubmed publisher
  32. Neidleman J, Luo X, Frouard J, Xie G, Hsiao F, Ma T, et al. Phenotypic analysis of the unstimulated in vivo HIV CD4 T cell reservoir. elife. 2020;9: pubmed publisher
  33. Fernandes R, Li C, Wang G, Yang X, Savvides C, Glassman C, et al. Discovery of surrogate agonists for visceral fat Treg cells that modulate metabolic indices in vivo. elife. 2020;9: pubmed publisher
  34. Pasciuto E, Burton O, Roca C, Lagou V, Rajan W, Theys T, et al. Microglia Require CD4 T Cells to Complete the Fetal-to-Adult Transition. Cell. 2020;182:625-640.e24 pubmed publisher
  35. Camu W, Mickunas M, Veyrune J, Payan C, Garlanda C, Locati M, et al. Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial. EBioMedicine. 2020;59:102844 pubmed publisher
  36. Fischer M, Ruhnau J, Schulze J, Obst D, Floel A, Vogelgesang A. Spermine and spermidine modulate T-cell function in older adults with and without cognitive decline ex vivo. Aging (Albany NY). 2020;12:13716-13739 pubmed publisher
  37. Janyst M, Kaleta B, Janyst K, Zagozdzon R, Kozlowska E, Lasek W. Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin. Arch Immunol Ther Exp (Warsz). 2020;68:20 pubmed publisher
  38. Oh D, Kwek S, Raju S, Li T, McCarthy E, Chow E, et al. Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer. Cell. 2020;181:1612-1625.e13 pubmed publisher
  39. Kuhny M, Forbes L, Çakan E, Vega Loza A, Kostiuk V, Dinesh R, et al. Disease-associated CTNNBL1 mutation impairs somatic hypermutation by decreasing nuclear AID. J Clin Invest. 2020;: pubmed publisher
  40. Beziat V, Tavernier S, Chen Y, Ma C, Materna M, Laurence A, et al. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med. 2020;217: pubmed publisher
  41. Martin E, Minet N, Boschat A, Sanquer S, Sobrino S, Lenoir C, et al. Impaired lymphocyte function and differentiation in CTPS1-deficient patients result from a hypomorphic homozygous mutation. JCI Insight. 2020;5: pubmed publisher
  42. Marotte L, Simon S, Vignard V, Dupré E, Gantier M, Cruard J, et al. Increased antitumor efficacy of PD-1-deficient melanoma-specific human lymphocytes. J Immunother Cancer. 2020;8: pubmed publisher
  43. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  44. Schafflick D, Xu C, Hartlehnert M, Cole M, Schulte Mecklenbeck A, Lautwein T, et al. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nat Commun. 2020;11:247 pubmed publisher
  45. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  46. Jimeno R, Lebrusant Fernandez M, Margreitter C, LUCAS B, Veerapen N, Kelly G, et al. Tissue-specific shaping of the TCR repertoire and antigen specificity of iNKT cells. elife. 2019;8: pubmed publisher
  47. Martínez Fábregas J, Wilmes S, Wang L, Hafer M, Pohler E, Lokau J, et al. Kinetics of cytokine receptor trafficking determine signaling and functional selectivity. elife. 2019;8: pubmed publisher
  48. Muhammad F, Wang D, Montieth A, Lee S, Preble J, Foster C, et al. PD-1+ melanocortin receptor dependent-Treg cells prevent autoimmune disease. Sci Rep. 2019;9:16941 pubmed publisher
  49. Ma A, Motyka B, Gutfreund K, Shi Y, George R. A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Hum Vaccin Immunother. 2020;16:756-778 pubmed publisher
  50. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  51. Pecher A, Kettemann F, Asteriti E, Schmid H, Duerr Stoerzer S, Keppeler H, et al. Invariant natural killer T cells are functionally impaired in patients with systemic sclerosis. Arthritis Res Ther. 2019;21:212 pubmed publisher
  52. Pham J. One Year at Cell: Looking Back and Moving Forward with Purpose. Cell. 2019;178:1273-1274 pubmed publisher
  53. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  54. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed publisher
  55. Leclerc M, Voilin E, Gros G, Corgnac S, de Montpreville V, Validire P, et al. Regulation of antitumour CD8 T-cell immunity and checkpoint blockade immunotherapy by Neuropilin-1. Nat Commun. 2019;10:3345 pubmed publisher
  56. Banga R, Rebecchini C, Procopio F, Noto A, Munoz O, Ioannidou K, et al. Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement. PLoS Pathog. 2019;15:e1007918 pubmed publisher
  57. Papaioannou E, Yanez D, Ross S, Lau C, Solanki A, Chawda M, et al. Sonic Hedgehog signaling limits atopic dermatitis via Gli2-driven immune regulation. J Clin Invest. 2019;129:3153-3170 pubmed publisher
  58. Fransen N, Crusius J, Smolders J, Mizee M, Van Eden C, Luchetti S, et al. Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. Brain Pathol. 2020;30:106-119 pubmed publisher
  59. Canete P, Sweet R, Gonzalez Figueroa P, Papa I, Ohkura N, Bolton H, et al. Regulatory roles of IL-10-producing human follicular T cells. J Exp Med. 2019;: pubmed publisher
  60. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  61. Han L, Hu J, Ma B, Wen D, Zhang T, Lu Z, et al. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis. Diagn Pathol. 2019;14:52 pubmed publisher
  62. Thauland T, Pellerin L, Ohgami R, Bacchetta R, Butte M. Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome. Front Immunol. 2019;10:753 pubmed publisher
  63. Lim S, Kim J, Jeon S, Shin M, Kwon J, Kim T, et al. Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients. Front Immunol. 2019;10:496 pubmed publisher
  64. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  65. Ye Y, Liu M, Tang L, Du F, Liu Y, Hao P, et al. Iguratimod represses B cell terminal differentiation linked with the inhibition of PKC/EGR1 axis. Arthritis Res Ther. 2019;21:92 pubmed publisher
  66. Pais H, Ruggero K, Zhang J, Al Assar O, Bery N, Bhuller R, et al. Surfaceome interrogation using an RNA-seq approach highlights leukemia initiating cell biomarkers in an LMO2 T cell transgenic model. Sci Rep. 2019;9:5760 pubmed publisher
  67. Binnewies M, Mujal A, Pollack J, Combes A, Hardison E, Barry K, et al. Unleashing Type-2 Dendritic Cells to Drive Protective Antitumor CD4+ T Cell Immunity. Cell. 2019;177:556-571.e16 pubmed publisher
  68. Talreja J, Talwar H, Bauerfeld C, Grossman L, Zhang K, Tranchida P, et al. HIF-1α regulates IL-1β and IL-17 in sarcoidosis. elife. 2019;8: pubmed publisher
  69. Remmerswaal E, Hombrink P, Nota B, Pircher H, ten Berge I, van Lier R, et al. Expression of IL-7Rα and KLRG1 defines functionally distinct CD8+ T-cell populations in humans. Eur J Immunol. 2019;49:694-708 pubmed publisher
  70. Lodygin D, Hermann M, Schweingruber N, Flügel Koch C, Watanabe T, Schlosser C, et al. β-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature. 2019;566:503-508 pubmed publisher
  71. Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, et al. Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease. Front Pharmacol. 2019;10:39 pubmed publisher
  72. Montel Hagen A, Seet C, Li S, Chick B, Zhu Y, Chang P, et al. Organoid-Induced Differentiation of Conventional T Cells from Human Pluripotent Stem Cells. Cell Stem Cell. 2019;24:376-389.e8 pubmed publisher
  73. Koppejan H, Jansen D, Hameetman M, Thomas R, Toes R, van Gaalen F. Altered composition and phenotype of mucosal-associated invariant T cells in early untreated rheumatoid arthritis. Arthritis Res Ther. 2019;21:3 pubmed publisher
  74. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  75. Harper I, Gjorgjimajkoska O, Siu J, Parmar J, Mulder A, Claas F, et al. Prolongation of allograft survival by passenger donor regulatory T cells. Am J Transplant. 2019;19:1371-1379 pubmed publisher
  76. Helmold Hait S, Vargas Inchaustegui D, Musich T, Mohanram V, Tuero I, Venzon D, et al. Early T Follicular Helper Cell Responses and Germinal Center Reactions Are Associated with Viremia Control in Immunized Rhesus Macaques. J Virol. 2019;93: pubmed publisher
  77. Dias J, Boulouis C, Gorin J, van den Biggelaar R, Lal K, Gibbs A, et al. The CD4-CD8- MAIT cell subpopulation is a functionally distinct subset developmentally related to the main CD8+ MAIT cell pool. Proc Natl Acad Sci U S A. 2018;115:E11513-E11522 pubmed publisher
  78. Wagner D, Amini L, Wendering D, Burkhardt L, Akyüz L, Reinke P, et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat Med. 2019;25:242-248 pubmed publisher
  79. Hoang T, Harper J, Pino M, Wang H, Micci L, King C, et al. Bone Marrow-Derived CD4+ T Cells Are Depleted in Simian Immunodeficiency Virus-Infected Macaques and Contribute to the Size of the Replication-Competent Reservoir. J Virol. 2019;93: pubmed publisher
  80. Ye W, Chew M, Hou J, Lai F, Leopold S, Loo H, et al. Microvesicles from malaria-infected red blood cells activate natural killer cells via MDA5 pathway. PLoS Pathog. 2018;14:e1007298 pubmed publisher
  81. Tai Y, Lin L, Xing L, Cho S, Yu T, Acharya C, et al. APRIL signaling via TACI mediates immunosuppression by T regulatory cells in multiple myeloma: therapeutic implications. Leukemia. 2019;33:426-438 pubmed publisher
  82. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  83. Inoue Y, Endo S, Matsuno N, Kikukawa Y, Shichijo T, Koga K, et al. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018;: pubmed publisher
  84. D Addio F, Vergani A, Potena L, Maestroni A, Usuelli V, Ben Nasr M, et al. P2X7R mutation disrupts the NLRP3-mediated Th program and predicts poor cardiac allograft outcomes. J Clin Invest. 2018;128:3490-3503 pubmed publisher
  85. Sayin I, Radtke A, Vella L, Jin W, Wherry E, Buggert M, et al. Spatial distribution and function of T follicular regulatory cells in human lymph nodes. J Exp Med. 2018;215:1531-1542 pubmed publisher
  86. Ondigo B, Ndombi E, Nicholson S, Oguso J, Carter J, Kittur N, et al. Functional Studies of T Regulatory Lymphocytes in Human Schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98:1770-1781 pubmed publisher
  87. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  88. Zemmour D, Zilionis R, Kiner E, Klein A, Mathis D, Benoist C. Single-cell gene expression reveals a landscape of regulatory T cell phenotypes shaped by the TCR. Nat Immunol. 2018;19:291-301 pubmed publisher
  89. Tobin L, Mavinkurve M, Carolan E, Kinlen D, O Brien E, Little M, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI Insight. 2017;2: pubmed publisher
  90. Jeffery H, McDowell P, Lutz P, Wawman R, Roberts S, Bagnall C, et al. Human intrahepatic ILC2 are IL-13positive amphiregulinpositive and their frequency correlates with model of end stage liver disease score. PLoS ONE. 2017;12:e0188649 pubmed publisher
  91. Meng W, Tang A, Ye X, Gui X, Li L, Fan X, et al. Targeting Human-Cytomegalovirus-Infected Cells by Redirecting T Cells Using an Anti-CD3/Anti-Glycoprotein B Bispecific Antibody. Antimicrob Agents Chemother. 2018;62: pubmed publisher
  92. Kyoizumi S, Kubo Y, Kajimura J, Yoshida K, Hayashi T, Nakachi K, et al. Fate Decision Between Group 3 Innate Lymphoid and Conventional NK Cell Lineages by Notch Signaling in Human Circulating Hematopoietic Progenitors. J Immunol. 2017;199:2777-2793 pubmed publisher
  93. Pinaud L, Samassa F, Porat Z, Ferrari M, Belotserkovsky I, Parsot C, et al. Injection of T3SS effectors not resulting in invasion is the main targeting mechanism of Shigella toward human lymphocytes. Proc Natl Acad Sci U S A. 2017;114:9954-9959 pubmed publisher
  94. Liaskou E, Jeffery L, Chanouzas D, Soskic B, Seldin M, Harper L, et al. Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals. Sci Rep. 2017;7:7652 pubmed publisher
  95. Papa I, Saliba D, Ponzoni M, Bustamante S, Canete P, Gonzalez Figueroa P, et al. TFH-derived dopamine accelerates productive synapses in germinal centres. Nature. 2017;547:318-323 pubmed publisher
  96. Meniailo M, Malashchenko V, Shmarov V, Gazatova N, Melashchenko O, Goncharov A, et al. Direct effects of interleukin-8 on growth and functional activity of T lymphocytes. Int Immunopharmacol. 2017;50:178-185 pubmed publisher
  97. de Wolf A, van Aalst S, Ludwig I, Bodinham C, Lewis D, van der Zee R, et al. Regulatory T cell frequencies and phenotypes following anti-viral vaccination. PLoS ONE. 2017;12:e0179942 pubmed publisher
  98. Zheng C, Zheng L, Yoo J, Guo H, Zhang Y, Guo X, et al. Landscape of Infiltrating T Cells in Liver Cancer Revealed by Single-Cell Sequencing. Cell. 2017;169:1342-1356.e16 pubmed publisher
  99. Allan D, Cerdeira A, Ranjan A, Kirkham C, Aguilar O, Tanaka M, et al. Transcriptome analysis reveals similarities between human blood CD3- CD56bright cells and mouse CD127+ innate lymphoid cells. Sci Rep. 2017;7:3501 pubmed publisher
  100. Watanabe R, Shirai T, Namkoong H, Zhang H, Berry G, Wallis B, et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J Clin Invest. 2017;127:2725-2738 pubmed publisher
  101. Domae E, Hirai Y, Ikeo T, Goda S, Shimizu Y. Cytokine-mediated activation of human ex vivo-expanded V?9V?2 T cells. Oncotarget. 2017;8:45928-45942 pubmed publisher
  102. Ventura E, Weller M, Burghardt I. Cutting Edge: ERK1 Mediates the Autocrine Positive Feedback Loop of TGF-? and Furin in Glioma-Initiating Cells. J Immunol. 2017;198:4569-4574 pubmed publisher
  103. Cottineau J, Kottemann M, Lach F, Kang Y, Vély F, Deenick E, et al. Inherited GINS1 deficiency underlies growth retardation along with neutropenia and NK cell deficiency. J Clin Invest. 2017;127:1991-2006 pubmed publisher
  104. Chen C, Sun W, Chen J, Huang J. Dynamic variations of the peripheral blood immune cell subpopulation in patients with critical H7N9 swine-origin influenza A virus infection: A retrospective small-scale study. Exp Ther Med. 2017;13:1490-1494 pubmed publisher
  105. Melis D, Carbone F, Minopoli G, La Rocca C, Perna F, De Rosa V, et al. Cutting Edge: Increased Autoimmunity Risk in Glycogen Storage Disease Type 1b Is Associated with a Reduced Engagement of Glycolysis in T Cells and an Impaired Regulatory T Cell Function. J Immunol. 2017;198:3803-3808 pubmed publisher
  106. Su S, Liao J, Liu J, Huang D, He C, Chen F, et al. Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Res. 2017;27:461-482 pubmed publisher
  107. Klinker M, Marklein R, Lo Surdo J, Wei C, Bauer S. Morphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity. Proc Natl Acad Sci U S A. 2017;114:E2598-E2607 pubmed publisher
  108. Lim A, Li Y, Lopez Lastra S, Stadhouders R, Paul F, Casrouge A, et al. Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation. Cell. 2017;168:1086-1100.e10 pubmed publisher
  109. Eyquem J, Mansilla Soto J, Giavridis T, van der Stegen S, Hamieh M, Cunanan K, et al. Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection. Nature. 2017;543:113-117 pubmed publisher
  110. Watanabe N, Bajgain P, Sukumaran S, Ansari S, Heslop H, Rooney C, et al. Fine-tuning the CAR spacer improves T-cell potency. Oncoimmunology. 2016;5:e1253656 pubmed publisher
  111. Asano T, Meguri Y, Yoshioka T, Kishi Y, Iwamoto M, Nakamura M, et al. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy. Blood. 2017;129:2186-2197 pubmed publisher
  112. Aagaard K, Lahon A, Suter M, Arya R, Seferovic M, Vogt M, et al. Primary Human Placental Trophoblasts are Permissive for Zika Virus (ZIKV) Replication. Sci Rep. 2017;7:41389 pubmed publisher
  113. Raposo R, de Mulder Rougvie M, Paquin Proulx D, Brailey P, Cabido V, Zdinak P, et al. IFITM1 targets HIV-1 latently infected cells for antibody-dependent cytolysis. JCI Insight. 2017;2:e85811 pubmed publisher
  114. Boardman D, Philippeos C, Fruhwirth G, Ibrahim M, Hannen R, Cooper D, et al. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection. Am J Transplant. 2017;17:931-943 pubmed publisher
  115. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  116. Lévy R, Okada S, Béziat V, Moriya K, Liu C, Chai L, et al. Genetic, immunological, and clinical features of patients with bacterial and fungal infections due to inherited IL-17RA deficiency. Proc Natl Acad Sci U S A. 2016;113:E8277-E8285 pubmed publisher
  117. Connor L, Tang S, Cognard E, Ochiai S, Hilligan K, Old S, et al. Th2 responses are primed by skin dendritic cells with distinct transcriptional profiles. J Exp Med. 2017;214:125-142 pubmed publisher
  118. Li J, Shayan G, Avery L, Jie H, Gildener Leapman N, Schmitt N, et al. Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk. Oncoimmunology. 2016;5:e1200778 pubmed
  119. Kadivar M, Petersson J, Svensson L, Marsal J. CD8??+ ?? T Cells: A Novel T Cell Subset with a Potential Role in Inflammatory Bowel Disease. J Immunol. 2016;197:4584-4592 pubmed
  120. Ju X, Silveira P, Hsu W, Elgundi Z, Alingcastre R, Verma N, et al. The Analysis of CD83 Expression on Human Immune Cells Identifies a Unique CD83+-Activated T Cell Population. J Immunol. 2016;197:4613-4625 pubmed
  121. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  122. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  123. Nagase H, Takeoka T, Urakawa S, Morimoto Okazawa A, Kawashima A, Iwahori K, et al. ICOS+ Foxp3+ TILs in gastric cancer are prognostic markers and effector regulatory T cells associated with Helicobacter pylori. Int J Cancer. 2017;140:686-695 pubmed publisher
  124. Byrareddy S, Arthos J, Cicala C, Villinger F, Ortiz K, Little D, et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy. Science. 2016;354:197-202 pubmed
  125. Gabanti E, Bruno F, Scaramuzzi L, Mangione F, Zelini P, Gerna G, et al. Predictive value of human cytomegalovirus (HCMV) T-cell response in the control of HCMV infection by seropositive solid-organ transplant recipients according to different assays and stimuli. New Microbiol. 2016;39:247-258 pubmed
  126. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  127. Di Marco Barros R, Roberts N, Dart R, Vantourout P, Jandke A, Nussbaumer O, et al. Epithelia Use Butyrophilin-like Molecules to Shape Organ-Specific γδ T Cell Compartments. Cell. 2016;167:203-218.e17 pubmed publisher
  128. Klarquist J, Tobin K, Farhangi Oskuei P, Henning S, Fernandez M, Dellacecca E, et al. Ccl22 Diverts T Regulatory Cells and Controls the Growth of Melanoma. Cancer Res. 2016;76:6230-6240 pubmed
  129. Pachnio A, Ciáurriz M, Begum J, Lal N, Zuo J, Beggs A, et al. Cytomegalovirus Infection Leads to Development of High Frequencies of Cytotoxic Virus-Specific CD4+ T Cells Targeted to Vascular Endothelium. PLoS Pathog. 2016;12:e1005832 pubmed publisher
  130. Beatson R, Tajadura Ortega V, Achkova D, Picco G, Tsourouktsoglou T, Klausing S, et al. The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9. Nat Immunol. 2016;17:1273-1281 pubmed publisher
  131. Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881-900 pubmed publisher
  132. Cheng H, Gaddis D, Wu R, McSkimming C, Haynes L, Taylor A, et al. Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J Clin Invest. 2016;126:3236-46 pubmed publisher
  133. Chen H, Händel N, Ngeow J, Muller J, Huhn M, Yang H, et al. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells. J Allergy Clin Immunol. 2017;139:607-620.e15 pubmed publisher
  134. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  135. Ashizawa T, Iizuka A, Nonomura C, Kondou R, Maeda C, Miyata H, et al. Antitumor Effect of Programmed Death-1 (PD-1) Blockade in Humanized the NOG-MHC Double Knockout Mouse. Clin Cancer Res. 2017;23:149-158 pubmed publisher
  136. Stadinski B, Shekhar K, Gomez Tourino I, Jung J, Sasaki K, Sewell A, et al. Hydrophobic CDR3 residues promote the development of self-reactive T cells. Nat Immunol. 2016;17:946-55 pubmed publisher
  137. Arbore G, West E, Spolski R, Robertson A, Klos A, Rheinheimer C, et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells. Science. 2016;352:aad1210 pubmed publisher
  138. Xu Y, Chaudhury A, Zhang M, Savoldo B, Metelitsa L, Rodgers J, et al. Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J Clin Invest. 2016;126:2678-88 pubmed publisher
  139. van der Heiden M, van Zelm M, Bartol S, de Rond L, Berbers G, Boots A, et al. Differential effects of Cytomegalovirus carriage on the immune phenotype of middle-aged males and females. Sci Rep. 2016;6:26892 pubmed publisher
  140. Goodier M, Rodríguez Galán A, Lusa C, Nielsen C, Darboe A, Moldoveanu A, et al. Influenza Vaccination Generates Cytokine-Induced Memory-like NK Cells: Impact of Human Cytomegalovirus Infection. J Immunol. 2016;197:313-25 pubmed publisher
  141. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  142. Akyol Erikci A, Karagoz B, Bilgi O. Regulatory T Cells in Patients with Idiopathic Thrombocytopenic Purpura. Turk J Haematol. 2016;33:153-5 pubmed publisher
  143. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed publisher
  144. Patel M, Kim J, Theodros D, Tam A, Velarde E, Kochel C, et al. Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma. J Immunother Cancer. 2016;4:28 pubmed publisher
  145. Miyawaki S, Kawamura Y, Oiwa Y, Shimizu A, Hachiya T, Bono H, et al. Tumour resistance in induced pluripotent stem cells derived from naked mole-rats. Nat Commun. 2016;7:11471 pubmed publisher
  146. Xu A, Bhanumathy K, Wu J, Ye Z, Freywald A, Leary S, et al. IL-15 signaling promotes adoptive effector T-cell survival and memory formation in irradiation-induced lymphopenia. Cell Biosci. 2016;6:30 pubmed publisher
  147. Stikvoort A, Sundin M, Uzunel M, Gertow J, Sundberg B, Schaffer M, et al. Long-Term Stable Mixed Chimerism after Hematopoietic Stem Cell Transplantation in Patients with Non-Malignant Disease, Shall We Be Tolerant?. PLoS ONE. 2016;11:e0154737 pubmed publisher
  148. Tuşaliu M, Zainea V, Mogoantă C, Dragu A, GoanŢă C, Niţescu M, et al. Diagnostic and therapeutic aspects in malignant sinonasal lymphoma. Rom J Morphol Embryol. 2016;57:233-6 pubmed
  149. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  150. Wattrang E, Thebo P, Lunden A, Dalgaard T. Monitoring of local CD8β-expressing cell populations during Eimeria tenella infection of naïve and immune chickens. Parasite Immunol. 2016;38:453-67 pubmed publisher
  151. Harper I, Ali J, Harper S, Wlodek E, Alsughayyir J, Negus M, et al. Augmentation of Recipient Adaptive Alloimmunity by Donor Passenger Lymphocytes within the Transplant. Cell Rep. 2016;15:1214-27 pubmed publisher
  152. Bal S, Bernink J, Nagasawa M, Groot J, Shikhagaie M, Golebski K, et al. IL-1?, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. Nat Immunol. 2016;17:636-45 pubmed publisher
  153. Goldstein J, Burlion A, Zaragoza B, Sendeyo K, Polansky J, Huehn J, et al. Inhibition of the JAK/STAT Signaling Pathway in Regulatory T Cells Reveals a Very Dynamic Regulation of Foxp3 Expression. PLoS ONE. 2016;11:e0153682 pubmed publisher
  154. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  155. Macdonald K, Hoeppli R, Huang Q, Gillies J, Luciani D, Orban P, et al. Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor. J Clin Invest. 2016;126:1413-24 pubmed publisher
  156. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  157. Flint S, Gibson A, Lucas G, Nandigam R, Taylor L, Provan D, et al. A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia. Haematologica. 2016;101:698-706 pubmed publisher
  158. Simon S, Vignard V, Florenceau L, Dreno B, Khammari A, Lang F, et al. PD-1 expression conditions T cell avidity within an antigen-specific repertoire. Oncoimmunology. 2016;5:e1104448 pubmed
  159. Thibaudin M, Chaix M, Boidot R, Végran F, Derangère V, Limagne E, et al. Human ectonucleotidase-expressing CD25high Th17 cells accumulate in breast cancer tumors and exert immunosuppressive functions. Oncoimmunology. 2016;5:e1055444 pubmed
  160. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  161. Liu L, Sommermeyer D, Cabanov A, Kosasih P, Hill T, Riddell S. Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy. Nat Biotechnol. 2016;34:430-4 pubmed publisher
  162. Procaccini C, Carbone F, Di Silvestre D, Brambilla F, De Rosa V, Galgani M, et al. The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements. Immunity. 2016;44:406-21 pubmed publisher
  163. Trivedi P, Bruns T, Ward S, Mai M, Schmidt C, Hirschfield G, et al. Intestinal CCL25 expression is increased in colitis and correlates with inflammatory activity. J Autoimmun. 2016;68:98-104 pubmed publisher
  164. Cao Y, Amezquita R, Kleinstein S, Stathopoulos P, Nowak R, O Connor K. Autoreactive T Cells from Patients with Myasthenia Gravis Are Characterized by Elevated IL-17, IFN-γ, and GM-CSF and Diminished IL-10 Production. J Immunol. 2016;196:2075-84 pubmed publisher
  165. Su S, Hu B, Shao J, Shen B, Du J, Du Y, et al. CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients. Sci Rep. 2016;6:20070 pubmed publisher
  166. James E, Gates T, LaFond R, Yamamoto S, Ni C, Mai D, et al. Neuroinvasive West Nile Infection Elicits Elevated and Atypically Polarized T Cell Responses That Promote a Pathogenic Outcome. PLoS Pathog. 2016;12:e1005375 pubmed publisher
  167. Li L, Jiang Y, Lao S, Yang B, Yu S, Zhang Y, et al. Mycobacterium tuberculosis-Specific IL-21+IFN-γ+CD4+ T Cells Are Regulated by IL-12. PLoS ONE. 2016;11:e0147356 pubmed publisher
  168. Soh K, Tario J, Colligan S, Maguire O, Pan D, Minderman H, et al. Simultaneous, Single-Cell Measurement of Messenger RNA, Cell Surface Proteins, and Intracellular Proteins. Curr Protoc Cytom. 2016;75:7.45.1-7.45.33 pubmed publisher
  169. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  170. Berges C, Chatterjee M, Topp M, Einsele H. Targeting polo-like kinase 1 suppresses essential functions of alloreactive T cells. Immunol Res. 2016;64:687-98 pubmed publisher
  171. Woodfolk J, Glesner J, Wright P, Kepley C, Li M, Himly M, et al. Antigenic Determinants of the Bilobal Cockroach Allergen Bla g 2. J Biol Chem. 2016;291:2288-301 pubmed publisher
  172. Whisenant T, Peralta E, Aarreberg L, Gao N, Head S, Ordoukhanian P, et al. The Activation-Induced Assembly of an RNA/Protein Interactome Centered on the Splicing Factor U2AF2 Regulates Gene Expression in Human CD4 T Cells. PLoS ONE. 2015;10:e0144409 pubmed publisher
  173. Yamagishi M, Katano H, Hishima T, Shimoyama T, Ota Y, Nakano K, et al. Coordinated loss of microRNA group causes defenseless signaling in malignant lymphoma. Sci Rep. 2015;5:17868 pubmed publisher
  174. Dimeloe S, Mehling M, Frick C, Loeliger J, Bantug G, Sauder U, et al. The Immune-Metabolic Basis of Effector Memory CD4+ T Cell Function under Hypoxic Conditions. J Immunol. 2016;196:106-14 pubmed publisher
  175. Kobayashi S, Watanabe T, Suzuki R, Furu M, Ito H, Ito J, et al. TGF-β induces the differentiation of human CXCL13-producing CD4(+) T cells. Eur J Immunol. 2016;46:360-71 pubmed publisher
  176. Deisting W, Raum T, Kufer P, Baeuerle P, Münz M. Impact of Diverse Immune Evasion Mechanisms of Cancer Cells on T Cells Engaged by EpCAM/CD3-Bispecific Antibody Construct AMG 110. PLoS ONE. 2015;10:e0141669 pubmed publisher
  177. Laborel Préneron E, Bianchi P, Boralevi F, Lehours P, Fraysse F, Morice Picard F, et al. Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the Skin Microbiota of Atopic Children on CD4+ T Cell Activation. PLoS ONE. 2015;10:e0141067 pubmed publisher
  178. Arvey A, van der Veeken J, Plitas G, Rich S, Concannon P, Rudensky A. Genetic and epigenetic variation in the lineage specification of regulatory T cells. elife. 2015;4:e07571 pubmed publisher
  179. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  180. Scottà C, Fanelli G, Hoong S, Romano M, Lamperti E, Sukthankar M, et al. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica. 2016;101:91-100 pubmed publisher
  181. Heigele A, Joas S, Regensburger K, Kirchhoff F. Increased susceptibility of CD4+ T cells from elderly individuals to HIV-1 infection and apoptosis is associated with reduced CD4 and enhanced CXCR4 and FAS surface expression levels. Retrovirology. 2015;12:86 pubmed publisher
  182. Mitson Salazar A, Yin Y, Wansley D, Young M, Bolan H, Arceo S, et al. Hematopoietic prostaglandin D synthase defines a proeosinophilic pathogenic effector human T(H)2 cell subpopulation with enhanced function. J Allergy Clin Immunol. 2016;137:907-18.e9 pubmed publisher
  183. Bézie S, Picarda E, Ossart J, Tesson L, Usal C, Renaudin K, et al. IL-34 is a Treg-specific cytokine and mediates transplant tolerance. J Clin Invest. 2015;125:3952-64 pubmed publisher
  184. Broos C, van Nimwegen M, Kleinjan A, Ten Berge B, Muskens F, In t Veen J, et al. Impaired survival of regulatory T cells in pulmonary sarcoidosis. Respir Res. 2015;16:108 pubmed publisher
  185. Gao Y, Zhang M, Li J, Yang M, Liu Y, Guo X, et al. Circulating FoxP3+ Regulatory T and Interleukin17-Producing Th17 Cells Actively Influence HBV Clearance in De Novo Hepatitis B Virus Infected Patients after Orthotopic Liver Transplantation. PLoS ONE. 2015;10:e0137881 pubmed publisher
  186. Djurisic S, Skibsted L, Hviid T. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G. Am J Reprod Immunol. 2015;74:427-44 pubmed publisher
  187. Moslem M, Eberle I, Weber I, Henschler R, Cantz T. Mesenchymal Stem/Stromal Cells Derived from Induced Pluripotent Stem Cells Support CD34(pos) Hematopoietic Stem Cell Propagation and Suppress Inflammatory Reaction. Stem Cells Int. 2015;2015:843058 pubmed publisher
  188. Biylgi O, Karagöz B, Türken O, Gültepe M, Özgün A, Tunçel T, et al. CD4+CD25(high), CD8+CD28- cells and thyroid autoantibodies in breast cancer patients. Cent Eur J Immunol. 2014;39:338-44 pubmed publisher
  189. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  190. Boer M, Prins C, van Meijgaarden K, van Dissel J, Ottenhoff T, Joosten S. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults. Clin Vaccine Immunol. 2015;22:778-88 pubmed publisher
  191. Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Pérals C, et al. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015;16:628-34 pubmed publisher
  192. Lee J, Jeong I, Joh J, Jung Y, Sim S, Choi B, et al. Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection. Clin Immunol. 2015;159:37-46 pubmed publisher
  193. Hanley P, Melenhorst J, Nikiforow S, Scheinberg P, Blaney J, Demmler Harrison G, et al. CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo. Sci Transl Med. 2015;7:285ra63 pubmed publisher
  194. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  195. Metcalf Pate K, Pohlmeyer C, Walker Sperling V, Foote J, Najarro K, Cryer C, et al. A Murine Viral Outgrowth Assay to Detect Residual HIV Type 1 in Patients With Undetectable Viral Loads. J Infect Dis. 2015;212:1387-96 pubmed publisher
  196. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  197. Rochman Y, Yukawa M, Kartashov A, Barski A. Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig. PLoS ONE. 2015;10:e0122198 pubmed publisher
  198. Rao T, Marks Bluth J, Sullivan J, Gupta M, Chandrakanthan V, Fitch S, et al. High-level Gpr56 expression is dispensable for the maintenance and function of hematopoietic stem and progenitor cells in mice. Stem Cell Res. 2015;14:307-22 pubmed publisher
  199. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  200. Bowcutt R, Malter L, Chen L, Wolff M, Robertson I, Rifkin D, et al. Isolation and cytokine analysis of lamina propria lymphocytes from mucosal biopsies of the human colon. J Immunol Methods. 2015;421:27-35 pubmed publisher
  201. Rissiek A, Baumann I, Cuapio A, Mautner A, Kolster M, Arck P, et al. The expression of CD39 on regulatory T cells is genetically driven and further upregulated at sites of inflammation. J Autoimmun. 2015;58:12-20 pubmed publisher
  202. Lehnhardt A, Strecker M, Eiermann T, Marget M, Thaiss F, Nashan B, et al. High B-cell activating factor is not associated with worse 3-year graft outcome in blood group-incompatible kidney transplantation with rituximab induction. Clin Transplant. 2015;29:359-64 pubmed publisher
  203. Yeh I, de la Fouchardiere A, Pissaloux D, Mully T, Garrido M, Vemula S, et al. Clinical, histopathologic, and genomic features of Spitz tumors with ALK fusions. Am J Surg Pathol. 2015;39:581-91 pubmed publisher
  204. Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Res. 2015;25:208-24 pubmed publisher
  205. Yu A, Snowhite I, Vendrame F, Rosenzwajg M, Klatzmann D, Pugliese A, et al. Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes. Diabetes. 2015;64:2172-83 pubmed publisher
  206. Afshar M, Richards S, Mann D, Cross A, Smith G, Netzer G, et al. Acute immunomodulatory effects of binge alcohol ingestion. Alcohol. 2015;49:57-64 pubmed publisher
  207. Laranjeira P, Pedrosa M, Pedreiro S, Gomes J, Martinho A, Antunes B, et al. Effect of human bone marrow mesenchymal stromal cells on cytokine production by peripheral blood naive, memory, and effector T cells. Stem Cell Res Ther. 2015;6:3 pubmed publisher
  208. Touzot M, Cacoub P, Bodaghi B, Soumelis V, Saadoun D. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease. Autoimmun Rev. 2015;14:370-5 pubmed publisher
  209. Nguyen L, Pan J, Dinh T, Hadeiba H, O Hara E, Ebtikar A, et al. Role and species-specific expression of colon T cell homing receptor GPR15 in colitis. Nat Immunol. 2015;16:207-213 pubmed publisher
  210. Campbell J, Ratai E, Autissier P, Nolan D, Tse S, Miller A, et al. Anti-?4 antibody treatment blocks virus traffic to the brain and gut early, and stabilizes CNS injury late in infection. PLoS Pathog. 2014;10:e1004533 pubmed publisher
  211. Bell C, Sun Y, Nowak U, Clark J, Howlett S, Pekalski M, et al. Sustained in vivo signaling by long-lived IL-2 induces prolonged increases of regulatory T cells. J Autoimmun. 2015;56:66-80 pubmed publisher
  212. Cousens L, Najafian N, Martin W, De Groot A. Tregitope: Immunomodulation powerhouse. Hum Immunol. 2014;75:1139-46 pubmed publisher
  213. Neulen M, Viertlboeck B, Straub C, Göbel T. Identification of novel chicken CD4⁺ CD3⁻ blood population with NK cell like features. Dev Comp Immunol. 2015;49:72-8 pubmed publisher
  214. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  215. Huss D, Mehta D, Sharma A, You X, Riester K, Sheridan J, et al. In vivo maintenance of human regulatory T cells during CD25 blockade. J Immunol. 2015;194:84-92 pubmed
  216. Willmann K, Klaver S, DoÄŸu F, Santos Valente E, Garncarz W, Bilic I, et al. Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity. Nat Commun. 2014;5:5360 pubmed publisher
  217. Dominguez Villar M, Gautron A, de Marcken M, Keller M, Hafler D. TLR7 induces anergy in human CD4(+) T cells. Nat Immunol. 2015;16:118-28 pubmed publisher
  218. Kamburova E, Koenen H, van den Hoogen M, Baas M, Joosten I, Hilbrands L. Longitudinal analysis of T and B cell phenotype and function in renal transplant recipients with or without rituximab induction therapy. PLoS ONE. 2014;9:e112658 pubmed publisher
  219. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  220. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  221. Zhang Q, Chabot Richards D, Evans M, Spengel K, Andrews J, Kang H, et al. A retrospective study to assess the relative value of peripheral blood, bone marrow aspirate and biopsy morphology, immunohistochemical stains, and flow cytometric analysis in the diagnosis of chronic B cell lymphoproliferative neoplasms. Int J Lab Hematol. 2015;37:390-402 pubmed publisher
  222. Balasa B, Yun R, Belmar N, Fox M, Chao D, Robbins M, et al. Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways. Cancer Immunol Immunother. 2015;64:61-73 pubmed publisher
  223. Alnabhan R, Madrigal A, Saudemont A. Differential activation of cord blood and peripheral blood natural killer cells by cytokines. Cytotherapy. 2015;17:73-85 pubmed publisher
  224. Yu J, Zuo Z, Zhang W, Yang Q, Zhang Y, Tang Y, et al. Identification of immunophenotypic subtypes with different prognoses in extranodal natural killer/T-cell lymphoma, nasal type. Hum Pathol. 2014;45:2255-62 pubmed publisher
  225. Antsiferova O, Müller A, Rämer P, Chijioke O, Chatterjee B, Raykova A, et al. Adoptive transfer of EBV specific CD8+ T cell clones can transiently control EBV infection in humanized mice. PLoS Pathog. 2014;10:e1004333 pubmed publisher
  226. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  227. Kreiser S, Eckhardt J, Kuhnt C, Stein M, Krzyzak L, Seitz C, et al. Murine CD83-positive T cells mediate suppressor functions in vitro and in vivo. Immunobiology. 2015;220:270-9 pubmed publisher
  228. Reichwald K, Jørgensen T, Skov S. TL1A increases expression of CD25, LFA-1, CD134 and CD154, and induces IL-22 and GM-CSF production from effector CD4 T-cells. PLoS ONE. 2014;9:e105627 pubmed publisher
  229. Jin J, Zhang W, Wong K, Kwak M, van Driel I, Yu Q. Inhibition of breast cancer resistance protein (ABCG2) in human myeloid dendritic cells induces potent tolerogenic functions during LPS stimulation. PLoS ONE. 2014;9:e104753 pubmed publisher
  230. Bending D, Pesenacker A, Ursu S, Wu Q, Lom H, Thirugnanabalan B, et al. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis. J Immunol. 2014;193:2699-708 pubmed publisher
  231. Arlehamn C, Seumois G, Gerasimova A, Huang C, Fu Z, Yue X, et al. Transcriptional profile of tuberculosis antigen-specific T cells reveals novel multifunctional features. J Immunol. 2014;193:2931-40 pubmed publisher
  232. Han L, Yang J, Wang X, Wu Q, Yin S, Li Z, et al. The E3 deubiquitinase USP17 is a positive regulator of retinoic acid-related orphan nuclear receptor ?t (ROR?t) in Th17 cells. J Biol Chem. 2014;289:25546-55 pubmed publisher
  233. Herrera A, Kim H, Bindra B, Jones K, Alyea E, Armand P, et al. A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2014;20:1737-43 pubmed publisher
  234. Pegram H, Purdon T, van Leeuwen D, Curran K, Giralt S, Barker J, et al. IL-12-secreting CD19-targeted cord blood-derived T cells for the immunotherapy of B-cell acute lymphoblastic leukemia. Leukemia. 2015;29:415-22 pubmed publisher
  235. Noyan F, Lee Y, Zimmermann K, Hardtke Wolenski M, Taubert R, Warnecke G, et al. Isolation of human antigen-specific regulatory T cells with high suppressive function. Eur J Immunol. 2014;44:2592-602 pubmed publisher
  236. Kim K, Chung B, Kim B, Cho M, Yang C. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology. 2015;144:68-78 pubmed publisher
  237. Campion S, Brodie T, Fischer W, Korber B, Rossetti A, Goonetilleke N, et al. Proteome-wide analysis of HIV-specific naive and memory CD4(+) T cells in unexposed blood donors. J Exp Med. 2014;211:1273-80 pubmed publisher
  238. Zhang M, Ma Z, Selliah N, Weiss G, Genin A, Finkel T, et al. The impact of Nucleofection® on the activation state of primary human CD4 T cells. J Immunol Methods. 2014;408:123-31 pubmed publisher
  239. Azzimonti B, Zavattaro E, Provasi M, Vidali M, Conca A, Catalano E, et al. Intense Foxp3+ CD25+ regulatory T-cell infiltration is associated with high-grade cutaneous squamous cell carcinoma and counterbalanced by CD8+/Foxp3+ CD25+ ratio. Br J Dermatol. 2015;172:64-73 pubmed publisher
  240. Pastille E, Bardini K, Fleissner D, Adamczyk A, Frede A, Wadwa M, et al. Transient ablation of regulatory T cells improves antitumor immunity in colitis-associated colon cancer. Cancer Res. 2014;74:4258-69 pubmed publisher
  241. Meira M, Sievers C, Hoffmann F, Rasenack M, Kuhle J, Derfuss T, et al. Unraveling natalizumab effects on deregulated miR-17 expression in CD4+ T cells of patients with relapsing-remitting multiple sclerosis. J Immunol Res. 2014;2014:897249 pubmed publisher
  242. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  243. Moreno Fernandez M, Joedicke J, Chougnet C. Regulatory T Cells Diminish HIV Infection in Dendritic Cells - Conventional CD4(+) T Cell Clusters. Front Immunol. 2014;5:199 pubmed publisher
  244. Gautron A, Dominguez Villar M, de Marcken M, Hafler D. Enhanced suppressor function of TIM-3+ FoxP3+ regulatory T cells. Eur J Immunol. 2014;44:2703-2711 pubmed publisher
  245. Helm O, Mennrich R, Petrick D, Goebel L, Freitag Wolf S, Roder C, et al. Comparative characterization of stroma cells and ductal epithelium in chronic pancreatitis and pancreatic ductal adenocarcinoma. PLoS ONE. 2014;9:e94357 pubmed publisher
  246. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  247. Grage Griebenow E, Jerg E, Gorys A, Wicklein D, Wesch D, Freitag Wolf S, et al. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression. Mol Oncol. 2014;8:982-97 pubmed publisher
  248. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed publisher
  249. Oetjen S, Mahlke C, Hermans Borgmeyer I, Hermey G. Spatiotemporal expression analysis of the growth factor receptor SorCS3. J Comp Neurol. 2014;522:3386-402 pubmed publisher
  250. Hodara V, Parodi L, Chavez D, Smith L, Lanford R, Giavedoni L. Characterization of ??T cells in naïve and HIV-infected chimpanzees and their responses to T-cell activators in vitro. J Med Primatol. 2014;43:258-71 pubmed publisher
  251. Peguillet I, Milder M, Louis D, Vincent Salomon A, Dorval T, Piperno Neumann S, et al. High numbers of differentiated effector CD4 T cells are found in patients with cancer and correlate with clinical response after neoadjuvant therapy of breast cancer. Cancer Res. 2014;74:2204-16 pubmed publisher
  252. Sereti I, Estes J, Thompson W, Morcock D, Fischl M, Croughs T, et al. Decreases in colonic and systemic inflammation in chronic HIV infection after IL-7 administration. PLoS Pathog. 2014;10:e1003890 pubmed publisher
  253. Chang S, Kohrt H, Maecker H. Monitoring the immune competence of cancer patients to predict outcome. Cancer Immunol Immunother. 2014;63:713-9 pubmed publisher
  254. Cairo C, Longinaker N, Cappelli G, Leke R, Ondo M, Djokam R, et al. Cord blood V?2V?2 T cells provide a molecular marker for the influence of pregnancy-associated malaria on neonatal immunity. J Infect Dis. 2014;209:1653-62 pubmed publisher
  255. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  256. Sumitomo S, Fujio K, Okamura T, Morita K, Ishigaki K, Suzukawa K, et al. Transcription factor early growth response 3 is associated with the TGF-?1 expression and the regulatory activity of CD4-positive T cells in vivo. J Immunol. 2013;191:2351-9 pubmed publisher
  257. Mitchell P, Afzali B, Fazekasova H, Chen D, Ali N, Powell N, et al. Helicobacter pylori induces in-vivo expansion of human regulatory T cells through stimulating interleukin-1β production by dendritic cells. Clin Exp Immunol. 2012;170:300-9 pubmed publisher
  258. Liang H, Reinhardt R, Bando J, Sullivan B, Ho I, Locksley R. Divergent expression patterns of IL-4 and IL-13 define unique functions in allergic immunity. Nat Immunol. 2011;13:58-66 pubmed publisher
  259. Xu H, Ye J, Chen Y, Zhang L, Huang J, Xian J, et al. Changes in the proportions of CD4(+)T cell subsets defined by CD127 and CD25 expression during HBV infection. Immunol Invest. 2012;41:290-303 pubmed publisher
  260. Ruffell B, Au A, Rugo H, Esserman L, Hwang E, Coussens L. Leukocyte composition of human breast cancer. Proc Natl Acad Sci U S A. 2012;109:2796-801 pubmed publisher
  261. Lee J, Hayman E, Pegram H, Santos E, Heller G, Sadelain M, et al. In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy. Cancer Res. 2011;71:2871-81 pubmed publisher
  262. Wu Y, Ren M, Yang R, Liang X, Ma Y, Tang Y, et al. Reduced immunomodulation potential of bone marrow-derived mesenchymal stem cells induced CCR4+CCR6+ Th/Treg cell subset imbalance in ankylosing spondylitis. Arthritis Res Ther. 2011;13:R29 pubmed publisher
  263. Antiga E, Quaglino P, Bellandi S, Volpi W, Del Bianco E, Comessatti A, et al. Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br J Dermatol. 2010;162:1056-63 pubmed publisher
  264. Huntington N, Legrand N, Alves N, Jaron B, Weijer K, Plet A, et al. IL-15 trans-presentation promotes human NK cell development and differentiation in vivo. J Exp Med. 2009;206:25-34 pubmed publisher
  265. Anderson A, Martens C, Hendrix R, Stempora L, Miller W, Hamby K, et al. Expanded nonhuman primate tregs exhibit a unique gene expression signature and potently downregulate alloimmune responses. Am J Transplant. 2008;8:2252-64 pubmed publisher
  266. Sodsai P, Hirankarn N, Avihingsanon Y, Palaga T. Defects in Notch1 upregulation upon activation of T Cells from patients with systemic lupus erythematosus are related to lupus disease activity. Lupus. 2008;17:645-53 pubmed publisher
  267. Amann M, Friedrich M, Lutterbuese P, Vieser E, Lorenczewski G, Petersen L, et al. Therapeutic window of an EpCAM/CD3-specific BiTE antibody in mice is determined by a subpopulation of EpCAM-expressing lymphocytes that is absent in humans. Cancer Immunol Immunother. 2009;58:95-109 pubmed publisher
  268. Yates J, Whittington A, Mitchell P, Lechler R, Lightstone L, Lombardi G. Natural regulatory T cells: number and function are normal in the majority of patients with lupus nephritis. Clin Exp Immunol. 2008;153:44-55 pubmed publisher
  269. Carvalho K, Maeda S, Marti L, Yamashita J, Haslett P, Kallas E. Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects. Immunology. 2008;124:206-14 pubmed publisher
  270. Chen X, Molino C, Liu L, Gumbiner B. Structural elements necessary for oligomerization, trafficking, and cell sorting function of paraxial protocadherin. J Biol Chem. 2007;282:32128-37 pubmed
  271. Yates J, Rovis F, Mitchell P, Afzali B, Tsang J, Garin M, et al. The maintenance of human CD4+ CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int Immunol. 2007;19:785-99 pubmed
  272. Borsellino G, Kleinewietfeld M, Di Mitri D, Sternjak A, Diamantini A, Giometto R, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood. 2007;110:1225-32 pubmed
  273. Yaddanapudi K, Palacios G, Towner J, Chen I, Sariol C, Nichol S, et al. Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. FASEB J. 2006;20:2519-30 pubmed publisher
  274. Wichlan D, Roddam P, Eldridge P, Handgretinger R, Riberdy J. Efficient and reproducible large-scale isolation of human CD4+ CD25+ regulatory T cells with potent suppressor activity. J Immunol Methods. 2006;315:27-36 pubmed
  275. Lawson C, Brown A, Bejarano V, Douglas S, Burgoyne C, Greenstein A, et al. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood. Rheumatology (Oxford). 2006;45:1210-7 pubmed
  276. Chen L, Cohen A, Lewis D. Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells. Biol Blood Marrow Transplant. 2006;12:160-71 pubmed
  277. Miglio G, Varsaldi F, Lombardi G. Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation. Biochem Biophys Res Commun. 2005;338:1875-83 pubmed
  278. Lopez Santalla M, Valeri A, Perez Blas M, Aguilera Montilla N, Gutierrez A, Lasa I, et al. Expression of CD45 and proliferative response to CD3 as suitable classification markers of patients with gastric adenocarcinoma. Cancer Immunol Immunother. 2006;55:744-8 pubmed
  279. Siliciano J, Siliciano R. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals. Methods Mol Biol. 2005;304:3-15 pubmed
  280. Iking Konert C, Ostendorf B, Sander O, Jost M, Wagner C, Joosten L, et al. Transdifferentiation of polymorphonuclear neutrophils to dendritic-like cells at the site of inflammation in rheumatoid arthritis: evidence for activation by T cells. Ann Rheum Dis. 2005;64:1436-42 pubmed
  281. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  282. Aguilera Montilla N, Perez Blas M, Valeri A, Lopez Santalla M, Rodríguez Juan C, Mencia A, et al. Higher proliferative capacity of T lymphocytes from patients with Crohn disease than from ulcerative colitis is disclosed by use of Herpesvirus saimiri-transformed T-cell lines. Scand J Gastroenterol. 2004;39:1236-42 pubmed
  283. Suskind D, Muench M. Searching for common stem cells of the hepatic and hematopoietic systems in the human fetal liver: CD34+ cytokeratin 7/8+ cells express markers for stellate cells. J Hepatol. 2004;40:261-8 pubmed
  284. Camara N, Sebille F, Lechler R. Human CD4+CD25+ regulatory cells have marked and sustained effects on CD8+ T cell activation. Eur J Immunol. 2003;33:3473-83 pubmed
  285. Hatachi S, Iwai Y, Kawano S, Morinobu S, Kobayashi M, Koshiba M, et al. CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid. J Rheumatol. 2003;30:1410-9 pubmed
  286. Valeri A, Perez Blas M, Gutierrez A, Lopez Santalla M, Aguilera N, Rodríguez Juan C, et al. Intrinsic defects explain altered proliferative responses of T lymphocytes and HVS-derived T-cell lines in gastric adenocarcinoma. Cancer Immunol Immunother. 2003;52:708-14 pubmed
  287. Ng W, Duggan P, Ponchel F, Matarese G, Lombardi G, Edwards A, et al. Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells. Blood. 2001;98:2736-44 pubmed
  288. Palmer E, Farrokh Siar L, Maguire van Seventer J, van Seventer G. IL-12 decreases activation-induced cell death in human naive Th cells costimulated by intercellular adhesion molecule-1. I. IL-12 alters caspase processing and inhibits enzyme function. J Immunol. 2001;167:749-58 pubmed
  289. Agrawal S, Marquet J, Plumas J, Rouard H, Delfau Larue M, Gaulard P, et al. Multiple co-stimulatory signals are required for triggering proliferation of T cells from human secondary lymphoid tissue. Int Immunol. 2001;13:441-50 pubmed
  290. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  291. Bank U, Reinhold D, Schneemilch C, Kunz D, Synowitz H, Ansorge S. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation. J Interferon Cytokine Res. 1999;19:1277-87 pubmed
  292. Uchiyama T, Nelson D, Fleisher T, Waldmann T. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells. J Immunol. 1981;126:1398-403 pubmed